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                 CHAPTER 1  
 
1. OXIDATIVE STRESS 
 
1.1 Definition 
Oxidative stress reflects an imbalance between the systemic 
manifestation of reactive oxygen species and a biological system’s 
ability to readily detoxify the reactive intermedies or to repair the 
resulting damage. 
Living organisms carry out their vital functions in an oxygen-rich 
environment  and the majority of them suits and lives thanks to this.  
In a paradoxical way, oxygen should cause damage to important 
biological macromolecules of great importance.  In biological systems 
a series of reactions that require energy occurs and cells use oxygen as 
an electron acceptor to produce energy. During these reactions , in 
physiological conditions, the production of free radicals occurs. The 
reason of  the production of free radicals can be understood by 
studying how chemical reactions occur and the particular structure of 
molecular oxygen, which is essential for our metabolism. The 
production of free radicals is useful for the functioning of the cells, 
subcellular  organelles, enzymes and for the synthesis and metabolism 
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of  biomolecules. When they are not opposed by the organic defenses 
that their reactive potential becomes harmful.  
Molecular oxygen is a di-radical  with two unpaired electrons in its 
outer orbitals. These electrons are at their lowest level of energy and 
occupy separate orbitals, but with spin oriented in the same direction. 
Each of these orbitals can accommodate another electron, but the 
acquisition of electrons by another molecule and the formation of a 
bond is prevented by the fact that the spins are parallel (spin-
restriction). Therefore, the spin reversal appears to be necessary for 
the formation of a bond. Molecular oxygen because of its status of  di-
radical and the phenomenon of spin-restriction, can not react with 
other free radicals. Chemically, a radical is a molecule containing a 
single unpaired electron in the orbital outermost, therefore tends to 
react with molecules of the surrounding environment and to which, by 
coming in contact, can subtract the electron needed to complete its 
orbital and achieve a steady state. The spin-restriction can be 
overcome with the assistance of catalyst such as, for example, the 
transition metals ions (iron and copper)  that transfer an electron to 
time with the correct spin from the molecule that is to be oxidized to 
the oxygen that is reduced. Redox reactions will generate free radicals, 
such as superoxide anion or hydroxyl radical, but also other molecular 
species that are not free radicals but possess a similar reactivity as 
hydrogen peroxide and singlet oxygen. The term “reactive oxygen 
species (ROS)“ was coined to indicate all radicals with this reactivity. 
ROS are naturally formed because of normal oxygen metabolism. 
However these free radicals are potentially able to create oxidative 
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damage via-interaction with biomolecules. Obviously, ROS are not 
only always bad for normal physiology but sometime useful. For 
instance, lower amounts of ROS produced during mitochondrial 
activity in normal cells acts as the signaling molecules. The level of 
antioxidants and normal biological antioxidants must be in balance. If 
the mentioned balance is interrupted, then toxic oxidative stress may 
happen. This imbalance usually happens during aging (as an axample) 
or it can be involved in some diseases and also appears as a 
consequence of the diseases. The role of ROS in cellar damage is well 
documented with implications in a broad range of degenerative 
alterations (tissue degradation, carcinogenesis, ageing and other 
oxidative stress relate diseases). 
 
1.2 Reactive oxygen species (ROS) 
 
1.2.1 Superoxide anion 
The superoxide anion is considered a free radical because it has an 
unpaired electron, although it not presents a particularly high 
reactivity. It is formed through the univalent reaction of a single 
electron. The superoxide radical can be formed at the level of two 
precise points of the mitochondrial respiratory chain: at the level of 
Complex I (NADH dehydrogenase) and Complex III (ubiquinone: 
cytochrome C reductase). In normal metabolic conditions, the 
Complex III is the main site of ROS production (Turrens 1997). In 
physiological conditions, high concentration of manganese superoxide 
dismutase enzyme in the matrix ensures that the basal level of 
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superoxide is neutralized before it can damage the cell. The overall 
redox balance of the cell turns out to be decisive as to what will 
happen to superoxide anion; in biological tissues, in non pathological 
conditions, it undergoes dismutation by superoxide dismutase (SOD) 
to generate O2, according to the reaction: 
2O2-. + 2H+   H2O2 + O2                                             [1] 
 
1.2.2 Hydrogen peroxide 
 Hydrogen peroxide (H2O2) is a reactive oxygen species and is 
produced by SOD depend dismutation reaction or is generated for 
direct production in some enzymatic reactions, as those catalyzed by 
L-amino acid oxidase or monoamine oxidase at the level of 
microsomes, peroxisomes and mitochondria. In physiological 
conditions, also H2O2 does not represent a particular risk for the cell, 
since it is rapidly neutralized by the action of catalase, a ubiquitary 
heme protein and glutathione peroxidase according to the reactions: 
H2O2 + 2e- + 2H+    2H2O                                          [2] 
 
H2O2 + 2GSH       2H2O + GSSG                                [3] 
 
Even though hydrogen peroxide can control cell signaling and 
stimulates cell proliferation at low levels, in higher concentrations it 
can initiate apoptosis in very hight levels it may create necrosis 
(Abdollahi et al. 2012; Saeidnia et al. 2013). 
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1.2.3 Hydroxyl radical 
The free radical produced in higher quantities is the superoxide anion. 
It may react with H2O2 to form the dangerous and powerful hydroxyl 
radical OH • (Haber-Weiss’s reaction): 
 
O2-• + H2O2   O2 + OH• + OH-                                            [4] 
 
The hydroxyl radical is formed especially in the redox reaction of 
H2O2 with iron or other transition metals according with Fenton 
reaction [5]. 
 
H2O2 + Fe2+    Fe3+ + OH• + OH-                                [5] 
 
Fe3+ so formed may, in turn, interact with a superoxide radical 
according to the reaction [6]: 
 
Fe3+ + O2-•   Fe2+ + O2                                               [6] 
 
regenerating Fe2+ which can again react according to [5] with a new 
molecule of H2O2.  
The production of OH• occurs only in the presence of free iron. Iron, at 
physiological pH, in plasma and tissues, is always present in bound , 
non-toxic form (Fe-hemoglobin, Fe-myoglobin, Fe-citochrome etc.) 
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but just a slight shift in pH toward acidosis promotes the separation of 
the metal from the protein and the initiation of radical reactions. 
The hydroxyl radical OH• is the agent responsible for the initial phase 
of many peroxidative processes in our tissues. Actually, in the 
presence of transition metals, hydrogen peroxide can be converted to 
the hightly reactive idroxyl radical, which is responsible for most of 
the oxidative damages to proteins, lipids, sugars and nucleic acids. 
Hydroxyl radical is also a a hallmark signaling molecule that is able to 
inactivate NF-kB, an important transcription factor involved in 
infiammatory response.  
 
1.2.4 Singlet oxygen 
A highly reactive form of molecular oxygen is singlet oxygen (1O2). It 
has the ability to oxidize the organic molecules damaging living 
systems. In vitro studies it showed that 1O2 oxidizes many organic 
molecules, including membrane lipids, proteins, amino acids, nucleic 
acids, nucleotides, carbohydrates and thiols. Singlet oxygen can be 
formed during the action of phagocytes when they are acting as agents 
of non-specific immunity. It has been hypothesized that 1O2  is a by-
product of lipid peroxidation and recent studies have shown that it can 
also be formed as the primary product of Haber-Weiss’s reaction [7] 
O2-•  + H2O2   1O2 + OH• + OH-                                    [7] 
 
Mitochondrial respiration generates a proton gradient and singlet 
oxygen perhaps as a signaling element that might be involved in 
oxidative stress and alkaline-induced cell death (Mates et al. 2012). 
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The creation of O2-•  following irradiation seems to be a main character 
of cell injury (Tominaga et al. 2012). Since manganese superoxide 
dismutase (Mn-SOD) removes extra O2-•  in the mitochondria to 
preserv them from oxidative damage, thus over-espression of Mn-
SOD reduce the levels of intracellular ROS and protects against cell 
death. 
  
1.3 Endogenous ROS formation  
 
The transformation of molecules in free radicals occurs through a 
chemical or physical reaction. In fact it is well known that many 
external agents such us UV rays and  X-rays are able to generate free 
radicals within biological systems. ROS can be also generated by the 
cell at the level of the mitochondrial respiratory chain. Experimental 
tests in vitro indicate that mitochondria convert 1-2% of the molecules 
of oxygen consumed in superoxide anion. Molecular oxygen is the  
ideal final acceptor of electrons in the mitochondrial respiratory chain,  
presenting high affinity for electrons, combined with a low reactivity 
in the absence of a catalyst. 
 
 
1.4 Reactive nitrogen species 
 
Nitric oxide and peroxynitrite, which is formed by the reaction 
between nitric oxide and superoxide, represent the reactive nitrogen 
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species that have attracted most interest. Class of enzymes belonging 
to the family of nitric oxide synthetase or synthase (NOS), using L -
arginine as a substrate, is assigned to the synthesis of nitric oxide 
(NO). The nitric oxide synthase are a family of  NADPH-dependent 
enzymes that oxidize the amino acid L-arginine to L-citrulline. NOS 
can be found in three different forms: neuronal, endothelial and 
inducible (iNOS). While the first two are calcium/calmodulin-
dependent, the iNOS is calcium independent and is expressed in 
response to different stimuli. The cell has the ability to produce large 
amounts of nitric oxide as it is able to regulate the expression of 
iNOS. NO exists in different chemical forms, with high chemical 
reactivity and has different biological roles. NO is produced by 
epithelial cells and this amount, if remains at physiological levels, 
appears to be essential for the proliferation, regolation and relaxation 
of vascular smooth muscle cells, for leukocyte adhesion and 
aggregation of platelets (Knowles et al. 1992). NO has different 
functions according to the  produced levels: at low levels, produced by 
neuronal constitutive NOS, serves as a neurotransmitter (Moncada et 
al. 1991), while produced at high levels  by activated macrophages 
and neutrophils it is an important mediator of the immune response 
(Bogdan 2001). 
 
1.6 ROS-producing enzymes contributing to  
      oxidative stress 
Several enzymes systems that can produce ROS  have been identified. 
Four seem to be of major importance: namely, NADPH oxidase, 
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xanthine oxidase, enzymes of the mitochondrial respiratory chain and 
dysfunctional eNOS. 
 
1.6.1 NADPH oxidases 
NADPH oxidase produces O2-• by transferring electrons from NADPH 
inside the cell across the cell membrane and reducing molecular 
oxygen. Several isoform of  NADPH oxidase (Nox) are found in 
various cell types of the vascular wall, including endothelial cells, 
smooth muscle cells and fibroblasts (Drummond et al. 2011). NADPH 
oxidase comprises multiple protein components that must be 
assembled in the cell membrane for the enzymes to become 
active(Drummond et al. 2011). In various animal model vascular 
disease, activation and/or upregulation of NADPH oxidase has been 
demonstrated in the vessel wall. Mice with a disrupted Nox1 gene 
exhibit smaller blood pressure increases in response to angiotensin II 
(Matsuno et al. 2005), whereas mice overespressing Nox1 in vascular 
smooth muscle exhibit increased O2-• production and greater blood 
pressure in response to angiotensin II (Dikalova et al. 2005). 
Disruption of the gene for the regulatory subunit p47phox reduces 
blood pressure responses to angiotensin II and diminishes 
atherogenesis in apolipoprotein E (ApoE) -/- mice (Barry-Lane et al. 
2001). 
 
1.6.2 Xanthine oxidase (XO) 
The main source of XO is the liver. It primarly synthesizes xanthine 
dehydrogenase, which is then converted to XO by proteolysis. The 
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release of XO from the liver is increased in hypercholesterolemia 
(White et al. 1996). The circulating XO can then adhere to endothelial 
cells by assiociating with endothelial glycosaminoglycans. XO 
donates electrons to molecular oxygen, thereby producing O2-•  and 
hydrogen peroxide. Allopurinol and oxypurinol are inhibitors of XO. 
Oxypurinol has been shown to reduce O2-•  production and improve 
endothelial function in blood vessels from hyperlipidemic animals 
(Ohara et al. 1993). This suggest a contribution of XO to endothelial 
ROS production, at least in hypercholesterolemia. There is evidence 
that endothelial cells themselves can express xanthine dehydrogenase 
and that this expression is upregulated in a redox-sensitive way when 
the activity of endothelial NADPH oxidase in increased. 
 
1.6.3 Enzymes of mitochondrial respiratory chain   
Mitochodria produce substantial amounts of O2-• in  ETC complex I 
and III. Complex I releases O2-•  into the mitochondrial matrix and is 
considered the main producer of O2-• due to reverse electron flow from 
complex II under low-ADP conditions. The matrix-localized 
mitochondrial SOD2 dismutates O2-•  to H2O2, which in turn is 
reduced to water by GPx or catalse. The importance of  SOD2 thus 
lies in the detoxification of O2-•  to prevent generation of ONOO- or 
oxidative damage of ETC proteins and mitochondrial DNA, which 
may otherways compromise mitochondrial function. Complex III also 
releases  O2-•  to the mitochondrial intermembrane space, where it is 
dismutated by SOD1, Mitochondrial ROS (Mito-ROS) production 
varies depending on several factors. Surprisingly, mitochondria 
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themselves are remarkably ROS sensitive. Oxidative damage lowers 
their activity and increases their ROS production (Davidson et al. 
2007). Mito-ROS promote the activity of other ROS sources (Schulz 
et al. 2012). Enhanced levels of mito-ROS are known to stimulate the 
release of mitochondrial apoptotic factors, with vascular cells showing 
differential sensitivity to stress conditions (Zeini et al. 2007). In the 
atherosclerotic process, an increase in cell death contributes to the 
formation of a necrotic core in plaque, which renders it unstable, 
favoring atherothrombosis (Madamanchi et al. 2007). This hightlights 
the role of oxidative stress in vascular diseases, a phenomen 
exemplified by the fact that elevated mito-ROS levels cause 
cardiomyopathy in SOD2-/- mice (Li et al. 1995). 
 
1.6.4 Dysfuntional uncoupled eNOS 
A key regulator of the vasoprotective function of the endothelium is 
generated by eNOS. Endothelial NO induces vasodilation, inhibits 
platelet aggregation and adhesion, and prevent atherogenesis 
(Forstermann 2008; Forstermann et al. 2011). Endothelial dysfunction 
is largely equivalent to the inability of the endothelium to generate 
adequate amounts of bioactive NO. Oxidative stress contributes 
markedly to endothelial dysfunction, primarily due to rapid oxidative 
inactivation of NO by excess O2-• . In a second step, persisting 
oxidative stress renders eNOS dysfunctional, such that it no longer 
produces NO, but rather O2-• . Evidence for eNOS uncoupling has 
been obtained in various animal models and in patients with 
endothelial dysfunction (Forstermann et al. 2011). Mechanistically, 
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depletion of BH4, an essential cofactor for the eNOS enzyme, is likely 
to be the major cause for eNOS uncoupling and endothelial 
dysfunction. ONOO-, the direct reaction product of NO and O2-•, is 
capable of oxidizing BH4, leading to BH4 deficiency (Forstermann 
2008) 
 
1.7 Relationship between oxidative stress and  
     cardiovascular diseases  
 
Oxidative stress plays a a central role in cardiovascular diseases (Li 
2013, Salari-abdollahi 2012). There are some risk factors of 
cardiovascular diseases including hypertension , hypercholesteremia, 
diabetes mellitus and cigarette smoking, as well as cardiovascular 
diseases that itself causes significant augmentation of ROS in the 
vascular wall, a situation that eventually culminates with oxidative 
stress. In the state of oxidative stress, enzymatic production of ROS 
exceeds the avaible antioxidant defence system. The ROS produced 
include free oxygen radicals, oxygen ions, and peroxides. Superoxide 
reacts with nitric oxide and lead to loss NO bioactivity.  The resulting 
peroxynitrite may cause dysfunction of eNOS and thus reduce NO 
production.  The reduced bioavailability  of vascular NO is the major 
mechanism of endothelial dysfunction observed in cardiovascular 
diseases.  In addition, vascular oxidative stress promotes atherogenesis  
througt numerous different mechanisms including the activation of 
redox-sensitive transcription factors and induction of lipid 
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peroxidation, protein oxidation, and mitochondrial and nuclear DNA 
damage (Forsterman 2010).     
 
1.7.1 Oxidative stress and hypertension 
Numerous studies in hypertensive patients have shown high levels of 
free radicals (Lacy et al. 1998). Endothelial cells are critical in 
combating hypertension as they play a key role in arterial relaxation. 
No is one of the agents that  with its vasodilatory action, helps to fight 
hypertension (Vallance 1998). In the presence of superoxide anion, 
NO has a very short half life as it is degraded by it. Therefore, the 
superoxide anion has the ability to modify endothelial function being a 
major determinant of nitric oxide (NO) biosynthesis and 
bioavailability. It acts therefore as a vasoconstrictor. eNOS can 
generate superoxide rather than NO in response to a variety of stimuli. 
As a result, eNOS may become a peroxynitrite generator, leading to a 
dramatic increase in oxidative stress, since peroxynitrite formed by the 
NO-superoxide reaction has additional detrimental effects on vascular 
function. So oxidative stress is evident in different types of 
hypertension, including angiotensin II-induced hypertension, 
spontaneously hypertensive rats (SHrs) – tha animal model of genetic 
hypertension, and deoxycorticosterone acetate (DOCA)-salt 
hypertension, which is  a low –renin/angiotensin hypertension model. 
In all three types of hypertension NADPH oxidase is likely to 
represent  the major and primary ROS source. Genetic deletion or 
inibhition of NADPH oxidase lowers blood pressure in hypertension 
models (Matsuno 2005, Landmesser 2003, Chalupski 2005). eNos 
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encoupling has been documented in all three and contributes 
significantly to vascular oxidative stress. eNOS encoupling in 
hypertension seems to be secondary to NADPH oxidase activation and 
mainly attributable to NADPH oxidase –mediated BH4 oxidation 
(Landmesser 2003). In angiotensin II-induced eNOS encoupling, BH4, 
deficiency  is additionally caused by reduced BH4, recycling from BH2 
due to downregolation of endothelial dihydrofolate reductase 
(Chalupski 2005).   
 
1.7.2 Oxitadive stress and diabetes 
Studies on animals and men suggest that oxidative stress plays an 
important role in the pathogenesis of both types of diabetes mellitus 
(Maritim et al. 2003). The increased production of ROS seems to be 
the main cause of the pro-inflammatory state and endothelial 
dysfunction which stands at the origin of vascular injury.  
Hyperglycemia stimulates cellular ROS production by different 
sources, with the mitochondrial ETC acting as the initial O2-• producer 
(Giacco et al. 2010). Overproduction of mitochondria derived  
O2-•  leads to activation of protein kinase C (PKC) and formation of 
advanced glycation end-products (AGEs). PKC and AGEs can, on the 
hand, activate NADPH oxidase and, on the other hand, inhibit eNOS 
activity through post-translational modifications (Funk et al. 2012). 
Uncoupling of eNOS has been demonstrated in streptozotocin induced 
type diabetes (Hink et al. 2001). BH4 oxidation and BH4 deficiency 
due to oxidative stress is likely to be a major cause of eNOS 
uncoupling under these conditions. Insulin resistance in type 2 
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diabetes may decrease GTP cyclohydrolase 1 activity and thus reduce 
BH4 de novo synthesis. The increased levels of angiotensin II in 
patients with diabetes may additionally reduce DHFR expression and 
thus BH4 recycling from BH2 (Chalupsky et al. 2005).  
 
 
1.7.3 Oxidative stress and atherosclerosis 
Atherosclerosis involves LDL entrapment in the arterial wall and an 
inflammatory response to the local LDL. The complexity of this 
process precludes a thorough discussion here. Nevertheless, common 
features of atherosclerosis include LDL oxidation, endothelial 
dysfunction, and inflammation (Stocker et al. 2004). Importantly, 
these 3 features of atherosclerosis all involve ROS in their 
pathophysiology. The oxidation of LDL is a well-described 
phenomenon in atherosclerosis. A number of enzyme systems have 
been proposed to contribute to LDL oxidation in vivo, and there are a 
number of reviews available on this topic (Levitan et al.). The most 
complete data concerning ROS-mediated LDL oxidation in vivo 
involve the contributions of NADPH oxidases and mitochondria. 
Human atherosclerotic coronary arteries contain increased 
immunostaining of p22phox (Azumi et al. 1999), an NADPH oxidase 
subunit. This protein is principally associated with Nox2 in lesional 
macrophages, and the p22phox expression level is positively 
associated with atherosclerosis severity (Sorescu et al. 2002). Animal 
studies using the ApoE-null atherosclerosis model indicate that mice 
lacking the Nox2 isoform of NADPH oxidase exhibit a 50 % 
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reduction in lesions, along with a marked decrease in aortic ROS 
production, suggesting that inhibition of Nox2 NAPDPH oxidase 
could limit atherosclerosis(Judkins et al. 2010). Humans express an 
NADPH oxidase isoform (Nox5) that is not found in rodents, and this 
oxidase may also contribute to blood vessel ROS as coronary arteries 
with atherosclerosis exhibit an increased expression level and activity 
of Nox5 (Guzik et al. 2008). Mitochondrial ROS have been implicated 
in many chronic diseases, including atherosclerosis (Corral et al. 
1992). Emerging data now link mitochondrial ROS production to the 
control of inflammation. For example, mitochondrial ROS are 
important for signaling events critical to innate immunity(West et al.) 
and activation of the NLRP3 inflammasome (Zhou et al. 2011) that is 
known to contribute to both animal and human atherosclerosis 
(Duewell et al.). As atherosclerotic lesions mature, they develop a 
fibrous cap overlying a lipid core. Acute vascular events are often 
caused by weakening of this fibrous cap and plaque necrosis is a key 
mechanism for fibrous cap weakening and rupture (Virmani et al. 
2000). The apoptosis of macrophages and the inability to clear these 
apoptotic cells are key contributors to plaque necrosis. When 
macrophages become apoptotic, they also stimulate a process known 
as autophagy in which the cells consume their own cellular 
components in an organized manner. It turns out that autophagy is an 
important adaptive mechanism for oxidative stress and without 
autophagy, ROS production (via Nox2 NADPH oxidase) is increased, 
and plaques become more prone to rupture. Thus, oxidative stress is 
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dependent upon autophagy, and recent data suggests that stimulating 
autophagy could have beneficial effects for atherosclerosis. 
 
1.7.4 Oxidative stress and myocardial injury 
ROS are the main cause of myocardial injury during 
ischemia/reperfusion (Duilio et al. 2001). In numerous studies 
conducted on infarcted animal models it was observed that the levels 
of ROS are very high (Cargnoni et al. 2000). It has been reported that 
the development of myocardial ischaemia/reperfusion injury is 
associated with an increase in the population of apoptotic cells in the 
peri-necrotic area (Zhao et al. 2002). Neutrophils are the primary 
source of ROS during reperfusion. Also endothelial cells and 
cardiomyocytes can generate ROS. ROS are produced from xanthine 
oxidase in endothelial cells, mitochondrial electron transport chain 
reactions in cardiomyocytes, and NADPH oxidase in inflammatory 
cells (Waypa et al. 2002). Even in the correlation between oxidative 
stress and myocardial injury a key role is attributed to the action of 
NADPH oxidase. In fact, it has been observed that the activity of this 
enzyme is increased in the tissue of the left ventricle in animals with 
heart failure (Li et al. 2002). In studies in rats suffering from 
myocardial infarction an increase in the production of ROS was 
observed, with a  decrease in the formation and bioavailability of 
endothelial NO (Wiemer et al. 2001). 
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1.7.5 Oxitadive stress and acute ischemia 
In recent decades myocardial ischemia is the leading cause of death 
worldwide. The major cause is the reduction of blood influx to the 
heart  due to the presence of atheromatous plaques in the arteries. In 
order to limite the damage due to this phenomenon, the reperfusion 
should be performed immediately after the ischemic insult, although 
reperfusion occuring after itself would be responsible for the 
formation of ROS (Bolli 1992). The increase in intracellular 
production of  ROS and therefore the increase of oxidative stress is 
not the only phenomenon that is found in the hearts subjected to 
damage of myocardial ischemia/reperfusion injury, but in addition 
cardiac dysfunction, reduction of antioxidant potential, increase of 
lipid peroxidation are present. It has been observed that exposing the 
heart or the sub-cellular organelles to oxidative stress, the same 
deleterious effects observed in hearts affected by I/R are detected 
(Siveski-Iliskovic et al. 1995; Dhalla et al. 1996). One aspect that can 
not be omitted is the fact that a small amount of ROS is produced 
during mitochondrial respiration; instead, during ischemia, the 
mitochondrial transporters are in a reduced state (Freeman et al. 
1982). An increased production of superoxide anion due to increase in 
the loss of electrons by the respiratory chain is observed. In 
reperfusion there is a further loss of electrons which causes an 
increase in the production of superoxide anion (Schmid-Schonbein 
1982).  
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1.7.6 Oxidative stress and smoke 
Compounds contained in cigarette smoke have been shown to activate 
endothelial NADPH oxidase (Jaimes et al. 2004) and impair 
mitochondrial function, threby elicitng mitochondrial oxidative stress 
(Csiszar et al. 2009). The increased O2-• and ONOO- production 
induces vascular inflammation and DNA damage and accelerates 
vascular ageing (Csiszar et al. 2009). Moreover, compounds from 
cigarette smoke may potentiate the pro-oxidative activity of LDL by 
inducing oxidative modifications of LDL (Steffen et al. 2012). The 
endothelial dysfunction seen in smokers is largely attributable to BH4 
deficiency due to oxidative degradation. Supplementation by BH4 can 
correct endothelial dysfunction in smokers (Heitzer et al. 2000).  
 
1.7.7 Oxidative stress and physical activity 
Physical activity increases the generation of free radicals in several 
ways. Two to 5% of oxygen used in the mitochondria forms free 
radicals. As oxidative phosphorylation  increases in response to 
exercise, there will be a concomitant increase in free radicals. 
Catecholamines that are released during exercise can lead to free 
radical production. Other sources of free radical increase with exercise 
are xanthine oxidase, NAD(P)H oxidase, and several secondary 
sources, such as the release of radicals by macrophages recruited to 
repair damaged tissue. This increase, even  if is required to meet the 
energy requirements on the other side leads to an increased production 
of free radicals. The amount of free radicals produced is directly 
proportional to the duration and intensity of exercise and inversely to 
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the degree of  trainingof those who practice it. In fact, training 
improves the antioxidant capacity of the organism and allows trained 
athletes  to more efficiently counteract the  produced free radicals. 
Conversely, the greater risk may be that, in an untrained individual, 
high intensity  physical exercise can lead to the production of free 
radicals not counteracted by the antioxidant defenses of the organism. 
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CHAPTER 2 
 
2. Ischemic preconditioning   
 
2.1.  Ischemia and reperfusion of the    
       myocardium 
Myocardial ischemia is the leading cause of death in the modern 
world. The main risk factors responsible for the onset of this disease 
are hypertension, ventricular hypertrophy, hyperlipidemia, 
atherosclerosis, diabetes, heart failure and aging. These factors can 
affect the development of ischemia and interfere with responses to 
cardioprotective interventions. A significant improve in the treatment 
of acute ischemic heart disease can be obtained by using procedures 
that enable the rapid restoration of blood flow in the ischemic area of 
the myocardium affected by the insult. These procedures are called of 
therapy of reperfusion. Although reperfusion is essential for the 
survival of the organ,it is, especially in the early stages, the cause of 
an aggravation of the injuries caused by the initial ischemic insult. The 
damageat the cardiac level induced by an ischemic event are not 
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solely due to ischemia, but also reperfusion (I/R damage). The 
complications of reperfusion include myocardial stunning and 
arrhythmias. The term stunning refers to a loss of contractility 
immediately following a sub-lethal ischemic insult. If the reperfusion 
and revascularization of the infarct zone are carried out promptly, 
myocardial contractility recover completely even though the recovery 
may take several hours or days. Contrary to an infarcted heart, the 
stunned myocardium recovers fully its activities. The identification of 
cardioprotective agents is very important to improve myocardial 
function and reduce the incidence of arrhythmias, delay necrosis and 
limit infarct size. 
In recent years, several studies have shown that the heart is capable of 
triggering mechanisms of adaptation to counteract the damage caused 
by I /R. These mechanisms are the main target of scientific research. 
Ischemia of short duration (2–10 min) protects the heart against 
damage that may arise with a next ischemic insult. This important 
phenomenon, known as ischemic preconditioning (PC), is an adaptive 
response, in which exposure to a brief  I/R significantly increases the 
heart's ability to support a next sequence of ischemic injury. 
Unfortunately,  the limitation of this mechanism is that it has a limited 
effect in time and in most cases ischemic attacks can not be predicted. 
This limitation is not present in the high-risk angioplasty where 
ischemic PC may have some practical utility. Recent studies 
conducted “in vivo” and in isolated hearts have demonstrated that we 
can achieve significant reductions in reperfusion damage, making a 
series of very brief re-thrombosis and coronary reperfusion at the 
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beginning of reperfusion. This phenomenon has been referred to by 
the term “ischemic postconditioning”. 
 
2.2 Reperfusion injury 
Irreversible ultrastructural changes occurr in the infarcted 
myocardium. If reperfusion of the tissue is carried out in a short time, 
changes may be considered reversible. Coronary occlusion lasting 20-
30 minutes leads to a transition from a state of reversible changes to a 
state of tissue injury and necrosis of cardiac cells (Jennings et al. 
1981). It has been shown that a diversified number of risk factors, 
influencing the onset of irreversible lesions such as the size of the 
affected area, the extent of collateral blood flow or the residual arterial 
flow, the ischemic duration (Miki et al. 1998). 
Reperfusion is a fundamental process for the recovery, as in the 
absence of reperfusion, no intervention is able to limit the 
development of infarction. In acute myocardial infarction, 
revascularization and reperfusion are the main therapies that  can save 
the organ which can be irreversibly damaged, limiting the extent of 
necrosis. Mortality for myocardial infarction, is linked to the duration 
of coronary occlusion (Bishopric et al. 2001). In the myocardium 
subjected to I /R, cell death can occur either by necrosis and by 
apoptosis; while the necrosis can be caused both by ischemia and  
reperfusion, apoptosis is induced mainly by reperfusion. The first 
experimental studies on apoptosis using  permanent coronary 
occlusion in rats, have shown that apoptosis is the principal cause of 
death of myocytes. Subsequently, most of the experimental tests, have 
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suggested that the number of cells undergoing apoptosis is probably 
less than the number of necrotic cells. It is not yet clear how these two 
processes are linked. The restoration of blood flow in the coronary 
artery branch, perfusing the ischemic myocardium, leads to the 
production of superoxide anion by different enzyme complexes. The 
superoxide anion, along with other ROS, exerts a strong oxidizing 
action on the myocardial fibers already damaged by ischemia. This 
situation leads the cells to apoptosis. Furthermore, the superoxide 
anion formed can react with nitric oxide to formed peroxide nitrite 
(NOOO-). The production of NOOO- reduces the bioavailability of  
NO but also participates with O2-• to tissue injury, being also equipped 
with oxidizing power. The deleterious action of O2-• is reduced due to 
its conversion to hydrogen peroxide by SOD. However, as in the 
presence of Fe2+ or Cu3+, the hydrogen peroxide can be converted into 
hydroxyl anion HO-•, that is more reactive than  superoxide anion  and 
hydrogen peroxide. An apparent initial decrease may be followed by 
an increase in toxicity. The cellular calcium overload contributes to 
myocardial reperfusion injury. This phenomenon, which manifests 
itself  under conditions of anoxia, is due to the malfunctioning of  
specific Ca2+ pumps, that are  situated on the  sarcolemma and on 
longitudinal tubules and  sodium pump with consequent entry of  Ca2+ 
and activation of the Na+/Ca2+  exchanger. The Ca2+ overload  also 
promotes the expression of pro-apoptotic genes. The nuclear factor 
NFkB plays a key role in reperfusion. NFkB accentuates the 
myocardial injury recalling inflammatory reactions. Its activation is 
induced by various agents, including hydrogen peroxide. Furthermore, 
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the reduced  NO availability , induced by I/R, causes an up-regulation 
of cell adhesion molecules that promotes the adhesion of leukocytes to 
the endothelium and their eventual migration to the myocardial fibers. 
NF-kB is also involved in activation of  gene transcription  coding for 
cell adhesion molecules. The cellular Ca2+ overload, ROS production,  
NFkB activation and cell adhesion molecules, can lead to the 
phenomenon of "no-reflow". This phenomenon increases the damage 
of the myocardium induced by the preceding ischemic insult. Until a 
few years ago,  ischemia was considered the cause of cell death that 
occurs basically due to the depletion of ATP. In these conditions the 
reperfusion appears to be essential to restore the synthesis of ATP,  
and thus to save the not damaged cells Reperfusion accelerates cell 
death of all those cells that are already irreparably damaged and 
sentenced to death. It is only in the last 10 years that some studies 
have identified the importance of mitochondria in this context. 
Mitochondria play a decisive role in determining cell fate during and 
after cellular stress (Kroemer et al. 2007). A fundamental component 
of the mitochondrial response to stress is the formation of 1- methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (mPTP), a multimeric structure 
ranging from the inner membrane to the outer membrane of the 
mitochondria (Halestrap et al. 2003). The only known component of 
the channel is cyclophilin  D, an isomerase that binds to and is 
inhibited by cyclosporin A (Crompton et al. 1988). The mPTP are non 
selective voltage dependent channels which are closed in normal 
physiological condition, when the mitochondrial membrane is 
impermeable to most solutes. Under conditions of cellular stress, the 
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opening of pores in the inner membrane, leads to loss of 
impermeability of the membrane and the rapid collapse of 
mitochondrial potential. The factors that determine whether and when 
the mPTP  open during I/R and the evidence that their openness can 
contribute to I/R, have been extensively studied over the past decades. 
The most recent hypothesis suggests that the opening of the pores 
does not occur during ischemia but during the early stages of 
reperfusion  and that inhibition of the opening of the pores protects the 
cell from necrotic death. The formation or inhibition of mPTP during 
reperfusion is the primary determinant of cell death or survival. Some 
studies show that the opening of the mPTP leads to cell die by 
necrosis, while others indicate that, depending on the extension of the 
opening of the mPTP, death occurs by apoptosis or necrosis (Bernardi 
et al. 2006). The corollary of this new vision is that specific 
manipulations, during reperfusion  offer the potential to attenuate cell 
death through cardioprotective strategies implemented during 
reperfusion. Therefore, PC, pharmacological treatments that mimic PC 
the postconditioning and  selected agents administered during 
reperfusion may protect the cell by attenuating the opening and 
extension of  mPTP during reperfusion. In conclusion, reperfusion is 
essential to save the infarcted organ. However, it can cause further 
irreversible damage. These damages are closely related to the previous 
ischemia that is related to the opening of mPTP in the first moments 
of reperfusion. Further researches are needed to evaluate the potential 
of reperfusion as a therapeutic intervention in order to maximize its 
benefits in acute myocardial infarction. 
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2.3 Preconditioning 
Preconditioning is the phenomenon whereby brief episodes of 
ischemia and reperfusion protect the heart from ischemic injury due to 
a subsequent ischemic insult. Thus, ischemic PC is a protective and 
adaptive mechanism obtained by short periods of ischemic stress 
rendering the heart resistant against another similar or greater 
ischemic event. PC was described by (Murry et al. 1986). In this 
experiment, authors exposed a group of open-chest dogs to a four 
cycles of 5 min coronary occlusions followed by 5 min of reperfusion 
and then exposed them to a 40 min coronary occlusion followed by 4 
day of reperfusion. Controls received only 40 min coronary 
occlusion., The result was that the dogs receiving 4 cyclic events of 5 
min occlusion, followed by 5 min reperfusion before extended 
ischemic episode, had a much smaller myocardial infract size 
compared with control group. This cardioprotective effect of 
preconditioning was attributed to a rapid metabolic adaptation of the 
ischemic myocardium. Any studies have highlighted the transient 
nature of this phenomenon. It has been demonstrated in rabbit heart 
that  protection against infarction, obtained by a single period of 5 min 
preconditioning , is ineffective if the interval between the PC stimulus 
and myocardial infarction protocol exceeds 60 min (Liu et al. 1991). 
In 1993, PC has been demonstrated to have a biphasic pattern (Kuzuya 
et al. 1993; Marber et al. 1993): an early phase, starting within 1h 
from preconditioning and ending after about 2h, and a late phase, 
developing after 24 hours of preconditioning and lasting up to 72 
hours. Since 1990 numerous articles have been published on various 
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aspects of PC in the myocardium and other tissues; most of them 
turned their attention to the classical preconditioning. 
 
2.4 Late preconditioning 
The late phase  develops 12 to 24h after the first PC stimulus and last 
72 to 96h, although the importance of protection may be somewhat 
less than in the early phase . Unlike the early phase, the late PC phase 
has an effect against myocardial infarction but also against myocardial 
stunning (Bolli 1996). Because of its 30- to 50-fold longer duration 
and the broader protection it provides many studies have  been 
focused on the late phase and its clinical exploitation (Bolli 2000). 
The late PC  was initially considered an adaptive phenomenon 
mechanistically distinct from the classic PC. Merber et all in their 
early studies examined the hypothesis that a transient stress (Marber et 
al. 1993), caused by I/R, could lead to the de novo synthesis of a 
cytoprotective protein. This protein is the 72kDa  heat shock protein  
or HSP72. They demonstrated a correlation between the increase of 
expression of this protein and the decrease of myocardial infarction 
damage, after 24 hours of ischemic preconditioning in rabbit hearts. A 
stress response is the induction of cytoprotective factors, such as 
cellular antioxidants and HSP. However, the factors influencing the 
induction of cytoprotective components, have not yet been well 
defined in mammals (Hoshida et al. 1993). The phenomenon of late 
PC can be induced by broad multiplicity of stimuli, which can be 
divided in non pharmacological and pharmacological. The first group 
includes exercise, hypoxia, ischemia, rapid ventricular pacing and heat 
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stress (Bolli 2000); the second consist of naturally occurring and often 
noxius agents, including endotoxin, ROS (Tang et al. 2005), tumor 
necrosis factor-α (TNF-α), TNF-β, leukemia inhibitory factor and of 
clinically applicable drugs including endotoxin derivates such as 
monophosphoryl lipid, adenosine receptor (AR) agonists (Takano et 
al. 2001), NO-releasing agents, opioid receptor agonists and α1-
adrenoceptor agonists. As mentioned above, late PC is the result of a 
complex cascade of signaling events that ultimately results in 
cardioprotection. Brief events of myocardial I/R, hypoxia, and heat 
stress are associated with metabolic perturbation that results in the 
generation of a wide variety of metabolites and ligands. Among these, 
adenosine, ROS, catecholamines, endogenous opioids and NO  act as 
chemical signals that trigger the development of the late PC. These 
agents can induce pharmacological PC in the absence of ischemia. 
Among these, NO has a key role in late PC. NO, formed in the early 
PC, is essential to induce this cardioprotective effect. Another study 
demonstrated that NO is also necessary to trigger late PC against 
myocardial infarction . It was observed that late PC is also induced by 
exposure to exogenous NO, because the treatment with NO donors in 
the absence of ischemia induces a loss of  protective effect against 
both myocardial stunning and infarction. Chemical signals trigger the 
development of late PC by inducing a series of complex signaling 
events. The signaling pathways involved in these mechanisms are 
protein kinase C (PKC), Src protein tyrosine kinases (Src PTKs), 
mitogen-activated protein kinases (MAPKs), JNKs, NFkB and signal 
transducers and activators of trascription (STATs). The general 
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pattern can be described starting from the interaction of NO derived 
from eNOS with the superoxide anion to form peroxynitrite, which 
activates PKC. This signaling pathway activates Src and Lck. The 
NFkB activation occurs thanks to the double phosphorylation of a 
serine and a tyrosine on the inhibitory protein IKB – α by PKC and 
tyrosine kinases. Cytoprotective proteins are induced, at the gene 
level, by NFkB. Among these are the inducible form of NOS (iNOS) 
and cyclooxygenase 2 (COX -2). NO produced by iNOS seems to 
regulate the activation of COX -2 in the preconditioned myocardium, 
inducing the generation of prostanoids, which is critical for the 
establishment of the cardioprotective phenotype (Bolli et al. 2002). 
The dependence of late PC by upregulation of iNOS and COX-2 is 
clearly demonstrated by several pharmacological and functional 
genomics studies, that involve pharmacological inhibition and genetic 
deletion of iNOS and COX-2 (Bolli et al. 2002). It is not yet known 
how prostanoids derived from COX-2 play their cytoprotective action 
and their relationships with other cytoprotective mechanisms, such as 
antioxidant enzymes (Ockaili et al. 2005), HSP, and inhibition of 
mPTP. Studies using microarrays have observed that PC is able to 
change the pattern of gene expression in rat heart. This suggests that 
complex cellular mechanisms are involved in the evolution of 
cardioprotection afforded by PC (Onody et al. 2003). 
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2.5 Postconditioning 
The main limitation of ischemic PC is  the not predictability of 
ischemic events except in special cases such as heart transplants or 
heart surgery. For this reason the identification of therapies that can be 
executed in the presence of heart infarction or in successive moments 
is of primary importance. The first studies on cardiac conditioning 
performed during the reperfusion were carried out for this aim. The 
results obtained led to the definition of a therapeutic treatment, 
ischemic postconditioning.  In anesthetized dogs subjected to 
prolonged myocardial ischemia, three occlusions of 30 seconds each 
from 30 seconds after the start of reperfusion, led to a significant 
reduction of the infarct zone, tissue edema and post-ischemic 
endothelial dysfunction, compared with dogs that had not undergone 
coronary occlusions. This technique allowed to obtain a protective 
effect almost equal to that obtained with ischemic preconditioning. 
Postconditioning  protocol reduces infarct extension only when 
performed in the early stage of reperfusion. Recently, the 
postconditioning has also been successfully applied in humans. In 
isolated rats hearts,  cardioprotection by postconditioning is mediated 
by inhibition of  ROS formation  and the first few minutes of 
reperfusion are critical for cardioprotective effects, due to the peak in 
ROS production. It should however be noted that, depending on the 
animal species and the duration of ischemia, the time at which the 
peak of ROS production appears is different. In fact, while in the 
rabbit heart subjected to 10 minutes global ischemia, the maximum 
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release of  ROS takes place 10 seconds after the start of reperfusion; 
in the hearts of dogs subjected to 90 minutes of ischemia, the 
maximum concentration was observed after 10 minutes. Recent data 
have shown that the postconditioning can reduce the subsequent ROS 
production and lipid peroxidation in isolated myocardial cells. In 
addition to this, the postconditioning leads to an increase in NO 
formation, which plays an important role in myocardial protection.  
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CHAPTER 3 
 
3. CARBONYL STRESS 
A common factor of degenerative diseases is oxidative stress, which is 
a serious imbalance between the production of reactive oxygen 
species and antioxidant defenses resulting in damage to the main 
biological macromolecules. In recent years there is a growing interest 
in carbonyl stress, a condition in which there is an imbalance between 
the production of glycant applies and the body's defenses against 
glycation. This condition is considered to negatively contribute to the 
onset and course of senescence (Xue et al. 2009) and of various 
diseases, among which diabetes and vascular complications associated 
with it (Ahmed et al. 2005), renal dysfunction (Agalou et al. 2005) 
Alzheimer's disease and cardiovascular disease. Protein glycation in 
recent years is one of the main targets of multiple studies. 
 
3.1 Nomenclature and classification 
 
In 1985, the Nomenclature Committee of the International Union of 
Biochemistry and the International Union of  Pure and Applied 
Chemistry chose  the term glycation to denote all those non-enzymatic 
and enzymatic reactions that bind a sugar to a protein or a peptide 
(Sharon 1986). Subsequently, the enzymatic modifications of proteins 
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and non-enzymatic modification of proteins by saccharides in 
processes of protein glycation forming glycated proteins (Lis et al. 
1993). This eventually led to selective use of the term glycation for 
non enzymatic modification of proteins by saccharides such that it is 
now accepted nomenclature. In older scientific literature, one of the 
most prominent glycated proteins, haemoglobin, has been called 
glycosylated haemoglobin, non-enzymatic glycosylated haemoglobin, 
glycohaemoglobin, glucosylated haemoglobin and other variants. 
Protein glycation involves the non-enzymatic attachment of a reducing 
sugar or sugar derivative to a protein. The term ‘‘reducing’’ related to 
the classical activity of saccharides with free aldehyde or ketone 
groups which reduced Benedict’s solution (Benedict 2002). Glycation 
is not available to non-reducing oligosaccharides where aldehyde or 
ketone groups of component monosaccharides have been converted to 
ketal and acetal groups of glycosidic bonds—such as in sucrose. In its 
earliest development, protein glycation was thought to be restricted to 
modification of amino groups of lysine residue side chains and N-
terminal amino acid residues. In more recent times, glycation of 
arginine residues by dicarbonyl metabolites has emerged as a major 
feature of protein glycation in physiological systems. There is also 
involvement of cysteine residues. Glycation of proteins occurs by a 
complex series of sequential and parallel reactions called collectively 
the Maillard reaction—named after the leading pioneer of glycation 
research, Louis Camille Maillard (1878–1936). Many different 
adducts may be formed. In the physiological setting, one of the 
important saccharides participating in glycation of mammalian 
36 
 
metabolism is glucose, and some of the most important saccaride 
derivatives are the reactive dicarbonyl metabolites such as 
methylglyoxal (MG) and glyoxal. 
Reactions involved in the process of glycation are classified  into early 
and advanced. In the early phase, glucose reacts with the amino 
residues of proteins to form initially glycosylamine which then was 
dehydrated to form a  Schiff base. Subsequently, the Schiff base 
undergoes an Amadori rearrangement to form fructosamine (Hodge 
1955). In the next phase, fructosamine is degraded to multiple stable 
adducts that are called advanced glycation end products (AGEs) 
 (Fig. 3-1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-1: Early protein glycation and AGE formation 
 
Numerous studies have shown that glucose can be converted into  
extremely reactive dicarbonyl species, such as α-oxoaldehydes. The α-
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oxoaldehydes have the ability to react with proteins forming directly 
AGEs; it has been observed also that the Schiff bases can be degraded 
directly in α-oxoaldehyde using a different process excluding the 
Amadori rearrangement. AGEs are  directly  formed by spontaneous 
modification of proteins by reactive dicarbonyl species.These are 
generated by the degradation of glycolytic intermediates and lipid 
peroxidation. AGEs are grouped under the name of all the adducts that 
are produced in the Maillard reaction. Important α-oxoaldehyde or 
dicarbonyl glycating agents are glyoxal, MG, and 3-deoxyglucosone 
(3-DG). Therefore, AGEs may be formed in glycation by glucose in 
pre- and post-Amadori product reactions, and indeed in processes 
where an Amadori product is not a precursor. AGEs may be formed in 
both the early and late stages of glycation processes. The term 
‘‘advanced glycation endproducts’’ is a misnomer in that AGEs are 
formed in both early and later, advanced stages of the Maillard 
reaction. 
 
3.2 Importance of protein glycation  
 
In biology, protein glycation is implicated in the low level endogenous 
damage to the proteome.  
The enzymatic  defenses of the organism against glycation consist of  
enzymes that repair the early glycated proteins and prevent glycation 
by metabolizing dicarbonyl glycating  agents responsible for this 
process at the physiological level : fructosamine 3- kinase (Delpierre 
et al. 2000), aldoketo reductase (Baba et al. 2009), and the glyoxalase 
system (Thornalley 2003). The imbalance between glycating species 
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and enzymatic defenses against glycation, in favor of the first, is 
called carbonyl stress. Itis considered in the same way of oxidative 
stress, and is believed to contribute negatively to aging and  diseases 
(Xue et al. 2009), for example diabetes and its vascular complications 
(Ahmed et al. 2005), renal dysfunction (Agalou et al. 2005), 
Alzheimer's and cardiovascular diseases (Ahmed et al. 2005; Rabbani 
et al. 2005). 
 
 
3.3 Methylglyoxal: an important glycant agent 
At the beginning, methylglyoxal was considered as a toxin or a 
environmental and/or bacterial metabolite (Cooper 1984). To date, we 
know that methylglyoxal is formed by spontaneous degradation in 
physiological systems of triosephosphates, glyceraldehyde 3- 
phosphate (GA3P) and dihydroxyacetone phosphate (DHAP) in all the 
organisms that have an anaerobic glycolytic metabolism. The GA3P is 
approximately 8 times more reactive of  DHAP in the degradation to 
methylglyoxal, but as the ratio between the concentrations of  DHAP 
and GA3P in the cell is about 20, both of these compounds are  
physiological important sources  for the formation of methylglyoxal in 
situ (Phillips et al. 1993). Other sources of methylglyoxal are 
considered to be the oxidation of acetone, this reaction is catalyzed by 
cytochrome P450 2E1 in the catabolism of threonine (Lyles et al. 
1992),  the degradation of glycated proteins by glucose and the 
degradation of monosaccharides (Thornalley et al. 1999). In addition 
to methylglyoxal, another dicarbonyl compound is glyoxal derived 
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from lipid peroxidation, and from degradation of monosaccharides 
(Thornalley et al. 1999). The quantification of physiological 
concentrations of glyoxal and methylglyoxal has been a big issue. 
Both compounds can be formed through multiple processes such as 
the degradation of monosaccharides, of glycated proteins and also 
during the preparation of the samples for the determination of their 
concentrations. For these reasons, the concentrations are often 
overestimated. To overcome this reason now methods for α-
oxoaldehyde analysis that involve the use of chemical derivatives of 
such substrates, thus improving the sensitivity of the method are 
applied. The more recent method involves the use of 1,2- 
diaminobenzene , to derivatize the substrate,  and the detection system 
with a gas chromatograph associated to mass spectrometer (GC-MS) 
(Selicharova et al. 2007). Recent studies have shown that the 
concentrations of glyoxal and methylglyoxal in  human plasma are 
around 100-120 nM, while at the cellular level are 1-5 µM for 
methylglyoxal  and 0.1-1 µM for glioxal (Dobler et al. 2006). In 
several studies in cell cultures and tissue, concentrations of 
methylglyoxal used to verify the effect of this metabolite are ten times 
higher than those considered cytotoxic. Using millimolar 
methylglyoxal concentrations in the has no relevance to the 
physiological level (Riboulet-Chavey et al. 2006). The rate of total 
cellular formation of MG was estimated to be ca. 125 µmol/kg cell 
mass/day (Thornalley 1988) which for an adult human of 25 kg body 
cell mass (Ellis et al. 2000) equates to a predicted whole bodyrate of 
formation of ca. 3 mmol MG/day. As total MG derived glycation 
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adduct excreted in urine of healthy human subjects was typically <10 
µmol/day (Thornalley 2003; Ahmed et al. 2005), it can be inferred 
that less than 1% MG formed endogenously modifies the proteome. 
Most of the formed MG (<99%) is metabolised by glyoxalase 1 
(Glo1) and aldo–keto reductase (AKRd) isozymes, which thereby 
constitute an enzymatic defence against MG glycation (see below). 
MG modifies proteins to form advanced glycation endproduct (AGE) 
residues. The major AGE formed is the arginine-derived 
hydroimidazolone Nd-(5-hydro-5-methyl- 4-imidazolon-2-yl)-
ornithine (MG-H1) formed via anintermediate 
dihydroxyimidazolidine. MG-H1 accounts for typically[90% 
adductstypically 2–4 µM (Phillips et al. 1993; Dobler et al. 2006; 
Nicolay et al. 2006) and the concentration of MG in human plasma is 
ca. 100 nM (Beisswenger et al. 1999; Nicolay et al. 2006). Estimates 
of MG concentrations that are markedly higher than this cannot be 
sustained given the reactivity of  MG with the proteome, the level of 
MG derived glycation adducts in the steady state and protein turnover 
(Thornalley 2005; Thornalley 2008). Overestimates are likely due to 
interferences in analytical methodology particularly degradation of 
derivatising agent and/or other sample components other than MG 
during pre-analytic processing. Although the concentration of MG in 
plasma is ca. 50,000- fold lower than glucose, MG has much higher 
intrinsic reactivity towards glycation than glucose, 10,000–50,000- 
fold higher (Thornalley 2005). It is, therefore, predicted that the 
formation of glycation adduct residues in proteins by MG in vivo 
occurs at fluxes approaching those of glucose. For the major glycation 
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adduct of glucose, Fructosyl-Lysine (FL) residues, there is a pathway 
of de-glycation and thereby repair of FL modified proteins catalysed 
by fructosamine 3-phosphokinase (Delpierre et al. 2000). Currently, 
there is no known mechanism of de-glycation of hydroimidazolone-
modified proteins. There is, however, slow dynamic reversibility of 
hydroimidazolone formation with de-glycation half-life of 12 days 
(Ahmed et al. 2002; Thornalley 2003). This implies that when there is 
a sustained decrease of the MG concentration, e.g. by induction of 
increased expression of GLO1, there is expected to be a later 
commensurate decrease in hydroimidazolone content of proteins. MG-
H1 adduct residues are released from proteins by cellular proteolysis. 
The MG-H1 free adduct thereby formed was the major quantitative 
glycation free adduct excreted in human and rat urine (Karachalias et 
al. 2000; Thornalley 2003). Proteins containing MG-H1 residues were 
predicted to have distorted or damaged structures (Ahmed et al. 2005; 
Dobler et al. 2006) and therefore may be targeted for proteolysis by 
the proteasome (Grune et al. 1996; Dudek et al. 2005; Hernebring et 
al. 2006). Lysosomal proteolysis is also important for degradation of 
long-lived cellular proteins, endocytosed extracellular proteins 
(Goldberg et al. 1997) and chaperone- mediated autophagy of cellular 
proteins (Franch et al. 2001). Release of MG-H1 free adduct from 
cells and tissues (Thornalley 2003) and decrease of glycated proteins 
with increased cellular 20S proteasome activity (Hernebring et al. 
2006) are consistent with targeting of MG-H1-modified proteins for 
proteasomal degradation. 
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3.4 Protein damage by glyoxal and methylglyoxal 
 
Glyoxal and methylglyoxal are considered two powerful reactive 
species involved in the process of glycation of proteins. The initial 
state of the process of  proteins glycation by glucose leads to the 
formation of FL and other residues of fructosamine. The final stage of 
the glycation process provides terminal stable adduct formation 
(Thornalley 2008). FL slowly  degrades to form AGEs; but glyoxal 
and methylglyoxal  may also derive from FL (Thornalley et al. 1999). 
Owever glyoxal and methylglyoxal directly and quickly react with 
proteins to form AGEs. For example, by adding 1 µM [C14]   
methylglyoxal to human plasma “in vitro”  and incubating at 37°C an 
irreversible binding of methylglyoxal to plasma proteins is obtained 
by 24 h (Thornalley 2005). The most important AGE proteins, from a 
quantitative point of view, are hydroimidazolones that are obtained by 
modification of arginine residues by glyoxal and methylglyoxal 
respectively Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-
H1) and Nδ-(5-hydro-4-imidazolon-2-yl)-ornithine (G-H1) 
(Thornalley et al. 2003) (Fig.3-2). Simultaneously also other minor 
adducts are formed by the modification of lysine residues by the 
action of glyoxal and methylglyoxal respectively: Nɛ-(1-
carboxyethyl)lysine (CEL) and Nɛ-(1-carboxymethyl)lysine (CML) 
and bis(lysil)crosslinks (GOLD e MOLD) (Ahmed et al. 2002). For 
glyoxal we can include also another adduct derived by modification of 
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arginine residues (Odani et al. 2001), the corresponding adduct 
derived from methylglyoxal Nω-carboxylmethyl-lisine (CMA) is 
unstable and not detectable. (fig.3-2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2: main AGE protein formed by glyoxal and methylglyoxal 
 
Protein glycation was originally seen as a post-translational 
modification that primarily affected the extracellular proteins. In 
particular, it was thought that AGEs were formed slowly during the 
course of the life and that the AGE concentration was the 
accumulation of glycation products in the course of existence. 
44 
 
For example, the accumulation of  CML and CEL residues was found 
in the skin (Verzijl et al. 2000). Hydroimidazolones have a lower life 
span in physiological conditions and their concentration depends on 
the balance between the amount of adducts that are formed and those 
that are degraded. The glycated proteins are also formed from short 
half-life cellular and extracellular proteins . The turnover of these 
proteins, governed by cellular proteolysis, leads to the release of the 
so-called glycation free adducts found in urine (Thornalley et al. 
2003). The damage caused by protein glycation results in structural 
changes, these proteins will be degraded by the proteasome (Goldberg 
2003). This is an efficient defense process since only a irrelevant 
portion of these adducts can be found at plasma level. Foods high in 
sugar and processed at high temperatures are a source of AGEs (Henle 
2003). But AGEs present in food proteins have a low bioavailability, 
in fact less than 10% of these is absorbed (Ahmed et al. 2005). This is 
due to the resistance of highly glycated food proteins to the 
proteolysis (Thornalley 2008) and to the fact that some AGEs inhibit 
intestinal proteases (Oste 1989). The highest concentration of 
foodborne AGE  is in the portal venous blood (Ahmed et al. 2004). 
AGEs are probably absorbed from foods as free AGEs or  glycated 
peptides. These are easily degradable when absorbed. The most 
common hydroimidazolones AGE (G-H1, MG-H1, CEL, CML) have 
a high renal clearance (Thornalley et al. 2003). Therefore, until renal 
function is optimal, glycation adducts and oxidated proteins absorbed 
with food, may represent only a minimal risk for the organism, being 
easily excreted via the urine (Thornalley 2005) (Fig.3-3). 
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Figure 3-3: Biodistribution scheme illustrating flows of formation and removal of  
glycation adducts  
                     
The harmful effects of the glycation process are caused by covalent 
crosslinks between proteins which confer a resistant effect against 
proteolysis (DeGroot et al. 2001). The biological impact of protein 
crosslink can lead to many different effects. Crosslinks of collagen 
causes a hardening of the vessels and of the joints, while the formation 
of cataracts is due to a crystalline damage. The proteasome is 
responsible for the elimination of glycated proteins. The accumulation 
of damage at the level of the proteasome causes a non-removal and 
accumulation of damaged proteins, with a consequent negative impact 
on the body's tissues.  
The modification of proteins is detrimental when the amino acid 
residues are located in sites of protein-protein, enzyme-substrate and 
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protein-DNA interaction. The most important modification of proteins 
by methylglyoxal and glyoxal concern the arginine residues. 
 
3.5 The glyoxalase system 
 
The glyoxalase system is present in the cytosol of all the cells and 
catalyses the conversion of α-oxoaldehydes  into the corresponding α-
hydroxyacids. Itis composed  of two enzymes, glyoxalase 1 (GLO1) 
and glyoxalase 2 (GLO2) and a catalytic amount of reduced 
glutathione. In particular, GLO1 catalyses the isomerization of the 
hemithioacetal, spontaneously derived from the reaction of the α-
oxoaldehyde, mehylglyoxal (CH3COCHO) and GSH, to S-D-
Lactoylglutathione. 
 
RCOCHO + GSH            RCOCH(OH)-SG            RCH(OH)CO-SG 
 
The Km value is 71-130µM and the Kcat is 7-11x 104 min-1. 
GLO2 catalyzes the conversion of  S-D-Lactoylglutathione in D-
Lactate  recostituting the GSH consumed in the GLO1-catalyzed 
reaction.  
 
RCH(OH)CO-SG + H2O               RCH(OH)COO- + GSH + H+ 
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Figure 3-4: The glyoxalase system 
 
The major physiological substrates for GLO1 are glyoxal and  
methylglyoxal; the last one  markendly  accumulates when GLO1 is 
inhibited in situ by cell permeable GLO1 inhibitors, by depletion of 
GSH and by gene silencing of gene encoding for GLO1 (Thornalley et 
al. 1996; Thornalley et al. 1999). Other substrates are 
hydroxypyruvaldehyde (HOCH2COCHO) and 4-5-dexovalerate  
H-COCOCH2CH2CO2H, formed during the reduction of α-
ketoglutarate and during the oxidative catabolism of a hee precursor 
(Grillo et al. 2008). The glyoxalase system, but particularly the action 
of GLO1 enzyme prevents the increase of these reactive  
α-oxoaldehydes in cells and thereby suppress the glycation process 
reactions. 
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3.5.1 Molecular properties of GLO1 
GLO1 enzyme is present in all human tissues, even if his activity in 
fetal tissues is 3 times higher than this of corresponding adult tissues, 
where is present at 0,2µg/mg protein concentration. Human GLO1 
enzyme is a dimer, expressed at a diallelic genetic locus which 
encodes  for two similar subunits in heteroygotes, and the three 
isoenzymes are called GLO1-1, GLO1-2 and GLO2-2. All the 
isoenzymes have molecular mass of 42 kDa (sequence) and 46 kDa 
(gel filtration) and pI values of 4,8-5,1. The human GLO1 is 
considered a Zn2+ metalloenzyme because each subunits contains one 
Zn2+ ion (Thornalley 1993). GLO1 from Escherichia coli is a 
 Ni2+-metalloenzyme (Clugston et al. 1998). 
 
3.5.2 Structure and functioning of GLO1 
184 amino acids are included in the post translation product of the 
human GLO1 gene. The N-terminal methionine in the post-
trascritional mechanism and the N-terminal alanine is stopped by an 
as-yet-unknown modification. The are 4 sites of phosphorylation. The 
structure of the complex GLO1 S-benzylglutathione was determined 
at the  2.2 Å resolution (Cameron et al. 1997) (Fig. 3-5). 
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Figure 3-5: representation of the crystal structure of  the human in a)monomeric 
b) dimeric form 
 
Each monomer countains two structurally equivalent domains. The 
active site is situated at the dimer interface, with the inhibitors and 
essential Zn2+ ion interacting with side chains of both subunits. The 
zinc binding site involves two structurally equivalent residues from 
each domain [Gln-33A, Glu-99A, His-126B, Glu-172B] and two 
water molecules in octahedral co-ordination (Cameron et al. 1997). 
The reaction catalyzed by GLO1 occurs with a mechanism that 
involves the proton transfer from C-1 to C-2 of the hemithioacetal, 
bound to the active site, to form an ene-diol intermediate, followed by 
a rapid ketonization to the thioester as the final product (Fig.3-6). 
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Figure 3-6: Catalytic mechanism of human GLO1 in the isomerization of    
                     R- hemithioacetal  (Himo et al. 2001) 
 
 
Both R- and S-forms of the hemithioacetal are bound in the active site 
of GLO1 and so both are deprotonated; the subsequent reprotonation 
of the putative ene-diol intermediate occurs stereospecifically to form 
the R-2-hydroxyacylglutathione derivate. It has been suggested that 
Glu-99 is the catalytic base for the R-substrate enantiomer and Glu-
172 the catalytic base for the S-substrate enantiomer. These two 
mechanisms lead to the formation of a cis-ene-diol intermediate co-
ordinated directly to  Zn2+ which then reprotonates C-2 
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stereospecifically to form the R-2-hydroxyacylglutathione (Himo et al. 
2001). 
methylglyoxal, glyoxal, and hydropyruvaldehyde produces 
respectively, S-D-lactoylglutathione, S-glycolylglutathione and S-L-
glyceroyglutathione, and are hydrolyzed to D-lactate, glycolate and L-
glycerate respectively by the GLO2 enzymes (Clelland et al. 1993). 
 
3.5.3 Role of GLO1 in anti-glycation defenses 
The formation of methylglyoxal is an intrinsic characteristic of the 
Embden-Meyerhof pathway or glycolysis; a direct consequence of the 
presence of triosephosphate, GA3P and DHAP, intermediates in 
glycolysis. The production of this dycarbonyl metabolite can be 
minimized by maintaining low triose phosphates concentration. 
Therefore, the production of methylglyoxal accounts for only 0,1-0,4 
% of glucotriose flux. 
A peculiarity of methyolglyoxal is the hight reactivity in glycation 
reactions in vivo, forming AGEs of protein and nucleotides. 
Methylglyoxal-derivate proteins AGEs are: Nɛ-carboxyethyl-lysine 
(CEL), from lysine and the hydroimidazolone derivative of arginine 
MG-H1 [Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine] and 
related structural isomers, among with is the predominat 
argpyrimidine. Nucleotide derived AGEs are: CEdG [N2-
1carboxyethyl)deoxyguanosine], dG-MG {6,7-dihydro-6,7-dihydroxy-
6-methyl-imidazo-[2,3-b]purine-9(8)one}, dG-MG2 [N2-(1-hydroxy-2-
oxopropyl)deoxyguanosine] (Thornalley 2003). Probably glyoxal and 
other GLO1 substrates may give rise to similar adducts. The 
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glyoxalase system is an efficient enzymatic detoxification system 
suppressing the formation of AGEs originated by methylglyoxal and 
glyoxal. Recently,  glycation adducts of cellular and extracellular 
proteins were quantified. These studies have shown that 0,1-2% of 
total cellular arginine is modified by methylglyoxal, the highest 
estimate being in human lens proteins of elderly subjects with low 
GLO1 activity (Ahmed et al. 2003). 
The experimental evidence that have allowed  to demonstrate the role 
of GLO1 in preventing the formation of AGEs derived from studies of  
normoglycaemic and hyperglycaemic endothelial cells culture. 
Hyperglycaemia increases concentration of methylglyoxal, D-lactate 
and cellular protein AGEs.  GLO1 overexpression   counteracted the 
increase in methylglyoxal and cellular protein AGEs, and increased D-
lactate concentration. This indicated that GLO1 has an important role 
in suppressing the formation of protein AGEs (Shinohara et al. 1998), 
preventing cell dysfunction and cell aging. GLO1 is a GSH-dependent 
enzyme. Under physiological conditions, the rate of hemithioacetal 
hydrolysis to GSH and methylglyoxal is of 103 times faster than the 
rate of isomerization by GLO1. This implies that “in vivo” there is a 
rapid pre-equilibrium between GSH, methylglyoxal and the 
hemithioacetal, and the activity of GLO1 is proportional to the amount 
of available GSH level. Cytotoxic effects caused by the accumulation 
of methylglyoxal and to a lesser extent of glyoxal, are due to the 
depletion of GSH  by oxidative and non-oxidative mechanisms. This 
indicates that methylglyoxal predominantly accumulates in conditions 
of oxidative stress and has the ability to contribute to the cytotoxicity 
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induced by oxidants (Abordo et al. 1999). The other accumulation of 
the highly reactive metabolites must be limited. For this reason it is 
capital the role of GLO1 that serves as a detoxification system toward 
these dycarbonilyc compounds  and therefore acts as an integral part 
of the defenses of the organism against enzymatic glycation. In 
diseases states, such as microbial infections and cancer the target is  to 
induce apoptosis of microbial organisms and tumour cells . In these 
conditions, the antitumor and antimicrobial activity were obtained 
through the use of cell-permeable GLO1 inhibitors. S-p-
bromobenzylglutathione (SpBrBzGSH) is a potent inhibitor of human 
GLO1. Diesterification of this inhibitor protects  this GSH conjugate 
against extracellular degradation by γ-glumyl transpeptidase and 
makes it cell permeable, therefore able to cross biological membranes. 
In the cell cytosol, SpBrBzGSH diesters are de-esterified and GLO1 is 
inhibited. S-p-bromobenzylglutathione-cyclopentyl diester showed a 
potent antitumor effect both “in vitro” and “in vivo” (Thornalley et al. 
1996). 
 
 
3.5.4 Role of methylglyoxal in the GLO1 regulation  
GLO1 substrates, methylglyoxal and glyoxal, leading to modifications 
of proteins, nucleotides and other biological macromolecules are very 
harmful to the organism. Our organism to counteract these damaging 
effects presents the glyoxalase system, composed by GLO1 and 
GLO2, that catalyzes the conversion of α-oxoaldehydes to the 
respective α-hydroxyacids (Thornalley 2003). Recent studies show 
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that GLO1 activity is regulated by GLO1 substrates and the process of 
glycation may have a functional role in the signal transduction 
pathway. A high  GLO1 activity is required, in conjunction with a 
high flow of methylglyoxal associated with an intense flow of triose 
phosphates and anaerobic glycolytic activity, to protect the proteome 
and the genome respectively  from functional and mutational damage.  
Secondly, the activation of the AGEs receptors (RAGE) by S100 
proteins found in increasing concentration in human plasma in 
inflammation, is associated with the decrease of the GLO1 expression.  
The induction of diabetes in wild type mice decreased the expression 
of GLO1, while the induction of diabetes in RAGE-deficient mice had 
no effect on the expression of the enzyme (Bierhaus et al. 2006).  The 
reduction of the GLO1 expression leads consequently to an increase of 
glycation (Thornalley 2003). AGEs  were co-localized mainly at the 
level of RAGEs. This may be due to the activation of  RAGEs by 
S100 proteins, by the local reduction of the  GLO1 expression and 
therefore by  the increase in AGE formation at the tissue level. This 
can be part of an inflammatory response that leads tomodify proteins 
with dicarbonyl-hydroimidazoline residues and route them to the 
proteasome for destruction.  
The proteins modified by MG then become the target for the 
destruction by the proteasome (Du et al. 2006). Finally,  GLO1 can be 
phosphorylated and the glycation of proteins may increase in case of 
apoptosis induced by tumor necrosis factor (αTNF). The regulation of 
GLO1 by methylglyoxal suggest a possible signaling role carried out 
by the glycation of proteins and nucleotides. 
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This role includes the development of malignant transformation 
(Thornalley 2003), cell death through the activation of apoptotic 
processes, erythrocyte apoptosis (Dobler et al. 2006) and activation of 
acute and/or chronic inflammatory processes. 
 
3.6 Effect of glycation in pathological conditions 
The accumulation of the adducts of glycation is associated with 
enzyme inactivation, protein denaturation and cell-mediated immune 
response. The excessive glycation of nucleotides is related to 
mutagenicity and apoptosis, whereas the excessive glycation of 
membrane phospholipids in lipid peroxidation and destruction of the 
phospholipid bilayer (Thornalley 2008). The body has a detoxification 
system that protects against cell and tissue damage induced by 
glycation (Thornalley 2003). This system is imperfect ; under normal 
physiological conditions, the adducts of glycation of proteins, 
nucleotides and phospholipids are generated spontaneously, but in 
small quantities. 
Imately approx 0.1-1 % of the lysine and arginine residues of proteins, 
one of 105 nucleotides at the DNA level and 0.1% of the basic 
phospholipids of membranes are modified.  Glycation adducts of 
proteins are removed by proteolytic enzymes at the level of 
proteasomes and lysosomes (Westwood et al. 1997). Glycation 
adducts of nucleotides are removed by repair systems DNA to excise 
nucleotides (Murata-Kamiya et al. 1999), and finally the AGEs of the 
phospholipids are removed by the lipid turnover (Requena et al. 
1997). However, the metabolism of these glycation adducts leads to 
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the genesis of additional products that are called glycation free 
adducts that are excreted primarily in the urine, along with glycation 
adducts  taken with food. The enzyme system counteracting the 
glycation is overwhelmed in some disease states, such as diabetes and 
renal dysfunction, resulting in accumulation of glycation products. A 
strong decline of the activity of GLO1 in aging was shown, so as to 
assume its involvement in physio-pathogenesis of senescence (Morcos 
et al. 2008). The main mechanism to remove glycation products from 
blood is the urinary excretion of the resulting metabolites, hence the 
marked accumulation of glycation free adducts in the case of clinical 
or experimental uremia (Rabbani et al. 2007). Even the oxidative 
stress is related to the glycation because of the depletion of GSH and  
NADPH that occur in oxidative stress, leading to a reduction in situ of 
the GLO1 activity (Abordo et al. 1999) and, consequently, an increase 
in the concentrations of glyoxal and methylglyoxal and glycation 
reactions. 
At the same time, also the glycated proteins by α-oxoaldehides may 
contribute to oxidative stress, increasing the proportion of  ROS such 
as superoxide anion, hydrogen peroxide and the hydroxyl radical. 
Glycation contributes to morbidity and mortality associated with high 
social impact diseases such as diabetes, cardiovascular diseases and 
kidney dysfunction, and seems to contribute in a determinant manner 
to the onset and course of others, such as Alzheimer's diseases, 
rheumatoid arthritis and senescence (Thornalley 2008). 
 
 
57 
 
3.6.1 Glycation in cancer 
Several studies have shown that the use of GLO1 inhibitors as 
SpBrBzGSH leads to an accumulation of methylglyoxal and glyoxal, 
an increase in the nucleotides glycation and induction of apoptosis in 
cancer cells  (Thornalley et al. 1996). It is not yet clear which is the 
mechanism by which these GLO1 substrates induce apoptosis, 
although it has been demonstrated the involvement of JNK and p38 
protein kinases (Sakamoto et al. 2001).  
It has also been shown that fibroblasts, overexpressing GLO1, are 
resistant to treatment with anticancer drugs such as doxorubicin and 
mitomycin C (Ranganathan et al. 1995). The GLO1 overexpression 
can, therefore, confer drug resistance against anticancer therapies. 
Accordingly, the use of inhibitors of GLO1 could have a twofold 
effect: to promote the glycation level of tumor cells by inducing 
apoptosis and reduce drug resistance by increasing the effectiveness of 
anticancer drugs. 
 
 
3.6.2 Role of AGE in ageing 
The increase in protein damage in aging was determined by analysis 
of damage markers to  long biological half-life proteins : typically it is 
absorbed the proteins the crystalline lens, which undergo a limited 
degradation by the proteasome  (Bloemendal et al. 2004), and skin and 
joints  collagen. These have respectively a 14.8 and 115 years half-life 
(Verzijl et al. 2000). The AGEs content in the crystalline lens 
increases significantly with the age increase of the subject (Ahmed et 
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al. 2003). Furthermore, an increase in the amount of CML and CEL 
was detected in fibroblasts of elderly subjects (Gonzalez-Dosal et al. 
2006). Finally, the content of CML and CEL in skin and joints 
collagen increases with advancing age (Verzijl et al. 2000).  
Studies in rats showed that the content of CML in skin collagen 
increases significantly with age (Cefalu et al. 1995). 
The immunoblotting analysis of skeletal muscle tissue of rats with 
 anti -AGE 6D12 able to recognize residues of CML and CEL shows 
an increase of the immunoreactivity of the β-enolase enzyme with 
aging (Snow et al. 2007);. Ageing in Wistar rats increases the content 
of the CML  residues of, but in the same animals, a similar increase of 
CEL residues in cardiac mitochondrial proteins was not found 
(Pamplona et al. 2002). The amount of CEL and CML in proteins of 
Drosophila melanogaster increases with age and is significantly 
higher in insects kept at 27 °C compared to those maintained at 18 °C, 
in which the mortality was significantly lower (Jacobson et al. 2010). 
In the C. elegans nematode, an accumulation with advancing age of 
the MH- H1 residues in mitochondrial proteins was abserved, and this 
process was, however, opposed and prevented by the overexpression 
of the GLO1 enzyme. GLO1 overexpression was able to decrease the 
glycation proteins induced by reactive species as methylglyoxal and 
glyoxal, reducing the amount of  MG -H1, G-H1 and CEL and helping 
to maintain lower levels of markers of oxidative damage. The 
prevention of oxidative stress induced by GLO1 overexpression is 
associated with a reduction of the structural changes of mitochondrial 
proteins by AGEs and thus prevent potential mitochondrial 
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dysfunction and concomitant increase in the formation of  ROS in 
aged nematodes (Morcos et al. 2008). 
 
 
3.6.3 Role of AGE in cardiovascular diseases 
Increased concentrations of methylglyoxal in hypertension were first 
suggested by studies of aortic smooth muscle cells (VSMCs) obtained 
from Wistar-Kyoto rats clinically hypertensive and from normotensive 
control rats. The concentrations of methylglyoxal measured in the 
aortic VSMCs and in the kidney (Wang et al. 2004), have appeared in 
all cases overestimated of about 10-100 times compared to the 
expected data. This can be attributed to the intrinsic formation of 
methylglyoxal during the processing of the samples; assaying the 
amount of this compound with the most reliable methods were found 
to be significantly lower MG values, 2 µM in rat blood  and 5 pmol / 
mg of protein in rat liver (Phillips et al. 1993). The “in vivo” 
accumulation of AGEs over time contributes to changes in the 
structure and function of the cardiovascular system and causesarterial 
stiffening, myocardial relaxation abnormalities, atherosclerotic plaque 
formation and endothelial dysfunction. One of the proposed 
mechanisms includes additional cross-linking of collagen by glycation 
of its free amino acids. The collagen-AGEs cross-linking will produce 
stiffness of blood vessels. Sims et al. in a histological study on 27 
samples of post-mortem aortas from people with diabetes,  found a 
relationship between AGEs accumulation and aortic stiffness (Ahmed 
et al. 2005). AGEs have also the ability to damage the cardiovascular 
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system through the reduction of LDL uptake by cell receptors. This 
mechanism involves the glycation of the LDL particle on the 
apolipoprotein B and in the phospholipid components of LDL. The 
glycated LDL is more susceptible to cross-linking with collagen on 
the arterial wall than non-glycated LDL, and it is not taken up into the 
cell and accumulates. Macrophages uptake of these modified LDL 
lead to foam cell formation, and the development of atheroma (Agalou 
et al. 2005; Hambsch et al. 2010). Another important study showed 
the role of increased androgens during and after menopause as a risk 
factor for cardiovascular damage  in women, with an associated 
increase in AGEs. A study in 106 postmenopausal women found 
significant correlations between testosterone and free androgen levels 
and AGEs after adjustment for age, body mass index, insulin 
resistance indices, and fasting glucose and insulin levels (Phillips et al. 
1993). 
In a patient with renal dysfunction and a rare GLO1 deficiency 
frequent CVD events occured, although no risk factors for these 
diseases were present (Miyata et al. 2001).  
In patients undergoing hemodialysis, the A419C polymorphism for 
the GLO1 gene was associated with an increased risk of  CVD 
complications (Kalousova et al. 2008). In addition, some studies have 
shown a high rate of mortality in patients homozygous for the 419CC 
GLO1 gene mutation  (Kalousova et al. 2010). The analysis of GLO1 
single nucleotide polymorphisms (SNPs) showed that the most 
common SNPs are in -7 (C or T) and 20203 (C or A) positions with 
respect to the start site of translation. 
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3.6.5 Role of AGEs in atherosclerosis and hypertension 
AGEs that are formed at low concentration contribute to the regulation 
of the physiological process of tissue remodeling , but can be 
detrimental when their production becomes abnormal with respect to 
anti-glycant defenses of the organism (Stitt et al. 2004). It was also 
suggested that some AGEs play a role in normal biological functions, 
while others, defined precisely AGE toxic, play a pathological role 
(Takeuchi et al. 2004). While these specific points are still unclear, 
there are more and more confirmations showing that AGEs are 
implicated in diseases such as atherosclerosis and hypertension (Wu 
2006). 
Studies on diabetes, a condition associated with insulin resistance with 
a high incidence of vascular complications, provide substantial 
evidence of the implication of AGEs in atherosclerosis. The 
concentrations of AGEs were elevated in both diabetic patients and in 
animal models of diabetes, and are associated with the changes 
observed in atherosclerosis (Fosmark et al. 2006). The research also 
shows that treatments  reducing AGEs or blocking the RAGE 
attenuate these vascular changes (Alderson et al. 2003). Individuals 
not suffering from diabetes, but with atherosclerosis, have high levels 
of the protein AGE-apo B  in the serum (Stitt et al. 1997), and AGEs 
have been identified in atherosclerotic lesions in animal models of 
rabbit (Palinski et al. 1995) or in humans (Sima et al. 2002). Studies 
conducted “in vivo” on hypertensive rats and on rats having diabetes-
induced hypertension show that MG and AGEs levels are elevated 
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(Wang et al. 2005). MG  administered in the diet to Wistar-Kyoto rats 
(WKY) causes an increase in AGE at the tissue level and is 
responsible for the onset of hypertension (Vasdev et al. 1998). In a 
study conducted in female subjects with pre-eclampsia, a condition of 
high blood pressure in pregnancy, the expression of RAGE is 
increased in vascular tissues  (Cooke et al. 2003). In patients with 
essential hypertension, the levels of soluble RAGE, which neutralize 
AGEs, are inversely correlated with blood pressure levels (Geroldi et 
al. 2005). AGEs tend to form crosslinks in the proteins and in 
particular bind to the long-lived proteins such as collagen or elastin 
(Aronson 2003). This contributes to vascular stiffening. Recently it 
has been shown that the increase of AGE concentration in plasma is 
associated with an increase of vascular stiffness in patients suffering 
of not treated essential hypertension (Brownlee 2001). Such an 
increase in vascular stiffness and the resulting systolic hypertension 
dramatically increase cardiovascular risk  (Safar 2001). This situation 
is very common in aging, but can be accelerated in diabetes or in other 
conditions where the formation of AGEs is increased (Schram et al. 
2005). Agents that contribute to the breaking of crosslinks formed by 
AGE proteins showed the ability to reduce the cross-linking and 
hardening of the arteries in animal models of diabetes (Wolffenbuttel 
et al. 1998), to improve vascular compliance in elderly subjects with 
atherosclerosis (Kass et al. 2001), to improve endothelial function 
(Zieman et al. 2007) and lower blood pressure in patients with systolic 
hypertension (Bakris et al. 2004). The role of AGEs in hypertension 
was also corroborated by animal studies showing that treatments that 
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target AGEs are able to reduce blood pressure (Midaoui et al. 2003). 
Other research on AGEs show that such glycation adducts not only 
alter  the structure but also the functionality of proteinaa which bind 
irreversibly, leading to changes typical of hypertension and 
atherosclerosis, including increased oxidative stress (Zhang et al. 
2006), endothelial cells disfunctions (Wautier et al. 2004), alteration 
of the reserves of calcium (Jan et al. 2005), onset of inflammatory 
processes (Kislinger et al. 2001) and changes in signal transduction 
pathways (Cohen et al. 2003).  
 
3.6.5 AGE and neurodegenerative diseases 
The processes underlying neurodegeneration are complex and may 
involve several aspects, such as excitotoxicity, mitochondrial 
dysfunction, abnormal protein aggregation and inflammation (Nicole 
et al. 1998). It has been hypothesized that the formation of ROS is a 
primary consequence only in certain aspects of the progression of 
neurodegeneration. In fact, numerous studies have shown that, in 
addition to ROS, reactive carbonyls as MG could contribute to 
neurodegeneration (Picklo et al. 2002), subjecting the cells to carbonyl  
stress characterized by an imbalance between accumulation and 
detoxification AGEs  
Glycation and AGEs, as noted in previous chapters, contribute to post-
translational modification of proteins. AGEs have been linked to the 
development of degenerative diseases including cataracts, and diabetic 
complications and AD. In AD, AGEs are accumulated in a age 
dependent manner  and  according to the stage of disease  in neurons 
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and microglia, and β -amyloid plaques, indicating that under these 
conditions there is an imbalance between the formation and 
degradation of proteins modified by AGEs (Luth et al. 2005). 
Among the various reactive carbonyl compounds and precursors of 
AGEs,  MG is probably the major  contributor to the intracellular 
formation of AGEs, as it is extremely consistently produced by the 
degradation of triosephosphates. MG concentration increases in 
specific pathophysiological conditions, for example, when the levels 
of triosi phosphates are high, when GSH concentration, 
cofactordetermining the speed of gliossalasi I, or is low, when the 
levels of  GLO1 expression are reduced, as it has been described in 
neurons and microglia in people older than 55 years (Kuhla et al. 
2007). 
Although the exact intracellular  MG concentration in neurons is not 
yet known, concentrations up to 300 mM were measured in CHO 
(Chinese hamster ovary ) cell culture (Chaplen et al. 1998). 
The AD  brain is characterized by two types of protein aggregates : 
extracellular plaques, which consist mainly of β-amyloid ( Aß ), and 
intracellular neurofibrillary tangles (NFTs), predominantly  composed 
of tau protein, protein associated with the microtubule (MAP-tau). 
Both proteins, Aβ and MAP-tau, are modified by AGEs (Yan et al. 
1994). Other proteins, not yet identified, are modified by AGEs, and 
gradually accumulated in the cortical areas of the brain in the 
advanced stages of AD (Luth et al. 2005). As a result of the formation 
of  AGEs, the proteins are heterogeneously modified in their side 
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chains, polymerize, thus becoming more insoluble and resistant to the 
action of proteases.  
Although several studies have shown that MG induces apoptosis in 
neuronal cells and not, probably through the activation of the family 
of the mitogen-activated protein kinase kinase or c-jun NH2-terminal 
(Kuhla et al. 2006), the molecular mechanisms underlying MG 
cytotoxicity  remain poorly understood. In a study of proteomics in the 
human neuroblastoma cell line SH-SY5Y , it has been shown that MG 
modifies the expression of several proteins that probably play a role in 
neurodegeneration . Another study examined samples of cerebrospinal 
fluid (CSF) from six AD patients, assessed by the Mini-Mental State 
Examination (MMSE), and six CSF samples from healthy controls. 
Weak increases in the mean values of free MG (22.1 ± 20.2 nM) in the 
group of patients compared to healthy controls (10.1 ± 5.2 nM) were 
observed but without statistical significance. Differences in the 
concentration of glyoxal between the two groups were not found 
(Kuhla et al. 2005). However, the concentrations of both compounds 
were about 5 to 7 times higher than that of human plasma samples 
(Odani et al. 1999), probably because the protein content in the CSF is 
much lower than in plasma, and then CSF proteins does not react 
completely with MG.  
Although the degree of protein modification by AGEs in senile 
plaques has not been quantified, it is probably much higher than that 
of plasma proteins, given that the half-life of proteins in senile plaques 
is estimated to be about 30 years compared to the much shorter-half 
of1-2 months of most of the plasma proteins.  
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It has been proposed that AGEs transmit their signals through the 
RAGE (Schmidt et al. 1994), which is a member of  the cell surface 
receptors of the immunoglobulin superfamily (Schmidt et al. 2000). 
Its series of ligands include AGEs,  anfoterine, the S100 calgranuline 
and fibrillar peptides including Aβ in the brain suffering from AD 
(Yan et al. 1998). Both AGE and Aß are present in senile plaques 
(Wong et al. 2001) and has been shown to up-regulate 
proinflammatory cytokines through RAGE and via NFkB-dependent 
pathway (Schmidt et al. 2000). This led to the conclusion that the Aβ-
RAGE interaction plays an important role in the pathophysiology of 
AD.  
It has been shown that both AGEs and Aß lead to a reduction of ATP 
levels in a dose dependent manner. Because ATP is important for 
many neuronal functions, including the maintenance of gradients of 
Na + / K +, low levels of ATP in the neurons of AD patients (caused 
by AGE and Aß) may directly influence the synaptic transmission and 
create the clinical picture of dementia (Kuhla et al. 2004).  
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CHAPTER 4 
 
4. Glucosinolates and Sulforaphane  
 
4.1 Chemical structure and properties 
Glucosinolates (GLS), an important phytocomponent group, are  
present at high levels in plants of the Cruciferae family, particularly 
Brassica, such as broccoli, cabbage and Brussels sprouts. Although 
abound 120 molecules have been identified, each plant contains up to 
4 different GLS in significant quantities (Fahey et al. 2001). In plants, 
the GLS and their metabolites have fungicidal  and bactericidal  
properties. Their composition in plants varies due to many factors: the 
climate, the type of crop, the various treatments to which they are 
subjected in different stages of collection, storage,  the preparation and 
consumption. From the biological point of view, they are a class of 
inactive compounds until they have been enzymatically hydrolysed to 
various bioactive break down products by the endogenous plant 
enzyme myrosinase. GLSs are (Z)-N-hydroximinosulfate esters, 
possessing a sulfur-linked β-D-glucopyranose moiety and an amino 
acid-derived side chain (Fig. 4-1). Side chain and sulfate group have 
an anti stereochemical configuration across the C =N double bond. 
The structure of the side chain is highly variable and may possess 
aliphatic (alkyl, alkenyl, hydroxyalkenyl, ω-methylthioalkyl, ω-
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sulfinyl-, and ω-sulfonylalkyl), aromatic (benzyl, substituted benzyl) 
or heterocyclic (indolyl) groups. The majority of the currently known 
GLSs may be subdivided according to their hydrolysis products into 
aliphatic and aromatic, terminally-unsaturated, β-hydroxy-, and 
indolyl GLSs, in which the first group includes a wide range of 
homologues (n = 3 to n = 11). A chemical classification of all so far 
discovered GLSs is reviewed by (Fahey et al. 2001). The presence of 
the sulfate group in the molecule confers strongly acidic properties on 
intact GLSs (Fig.4-2). Thus, they are non-volatile and occur as salts 
with the GLS anion usually counterbalanced by potassium. 
 . 
 
 
Figure 4-1: General structure of the GLS 
 
Many of the biological effects at the base of the health properties of 
these vegetables are attributed not to the GLS but to their hydrolysis 
products. The hydrolysis reaction is catalyzed by myrosinase enzyme 
which is located in separate compartments within the plant tissues, 
and takes place when, due to the disintegration of the tissues, the 
enzyme is in contact with the substrate (Cottaz et al. 1996). The GLS 
are present in all parts of the plant, but with quantitative and 
qualitative differences, for example in the flowers the total amount 
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may be 10 times higher than in other plant tissues and represent 10% 
of the total (Holst et al. 2004) 
Myrosinase is a thioglucoside glucohydrolase that hydrolyzes the 
glucosinolate molecule, leading to the formation of glucose, sulfate 
and unstable aglycone, thyohydroximate-O-sulfonate. The last one 
undergoes a spontaneous rearrangement which leads to a wide variety 
of products, whose chemical structure depends on the initial side chain 
of the GLS and the reaction conditions (Ludikhuyze et al. 2000) 
(Fig.4-2). At pH 6-7 the most common products are isothiocyanates 
(ITC). Among  them there is a compound that has attracted the 
attention of researchers. This compound is sulforaphane (SF) [4 - 
(methylsulfinyl) butyl - isothiocyanate], produced by the hydrolysis of 
the corresponding glucosinolate, the glucoraphanin, which has been 
studied for its anti-inflammatory and chemopreventive properties. 
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Figure 4-2: Products of  GLS hydrolysis  
 
4.2 Metabolism of glucosinolates 
Understanding of factors, that limit the release of phytochemicals 
from the food matrix, the degree of absorption and their fate in the 
body,  is essential to determine their mechanisms of action and their 
role in maintaining health. The term "bioavailability" describes all 
these aspects. It was coined by the Food and Drug Administration 
(FDA) as the amount to which a functional group with therapeutic 
action is absorbed and becomes available at the site of action. The 
concept of bioavailability includes:  
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1. The release and dissolution of a compound to be subsequently 
absorbed (bioaccessibility)  
2. The absorption  
3. The tissue distribution  
4. The metabolism  
5. The excretion 
These phases are represented in figure 4-3. 
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Figure 4-3: Path of  phytocomponents through the organism 
 
4.2.1 Release and absorption 
The term release means the release of the compound from the food 
matrix and its dissolution in biological fluids. These steps are crucial 
for the mixture arrives to the surface of the intestinal epithelium in the 
most appropriate form to be absorbed by enterocytes or to cross the 
epithelial layer through the cell junctions. 
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The release from the food matrix and the formation of hydrolysis 
products of GLS depends on several factors : 
1. GLS Concentration in plants 
2. Hydrolysis due to the damage of plant tissues 
3. Physical and chemical characteristics of the GLS and the 
corresponding ITC and their stability 
4. Level of rupture of the tissues during mastication 
5. Digestion 
In addition to the concentration of GLS and food treatments also the 
matrix affects the release and absorption (Conaway et al. 2000). 
The dissolution of a compound is determined by its solubility in an 
aqueous environment, by the ionization (pKa) and the lipophilicity 
that is defined by log P. This is the octanol-water partition coefficient, 
which is a crucial factor for the partition to the side of the plasma 
membrane. To obtain optimal absorption at the intestinal level the 
value of log P should be in a range from 0.5 to 2.0. The GLS would be 
able to cross the cell membrane  through a carrier or through aqueous 
pores. The value log P value, for the GLS degradation products, not 
depends on the structure of the side chain and varies from 0:23 to 4:37 
(Cooper et al. 1997). The presence of a glucoside group in the 
molecule can indicate an active transport through the glucose 
transporter, but in vitro studies have shown that this does not happen. 
A facilitated transport could be used. The  GLS degradation products, 
compared to the parent compounds, are much more lipophilic and 
have a lower molecular weight, so their absorption can take place, at 
least in part, by passive diffusion. SF has a log P value of 0.72 and a 
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molecular weight of 177 g / mol (Cooper et al. 1997).The ITC are 
conjugated with GSH by the glutathione-S-transferase enzyme. It was 
observed that hight amounts of GSH within the cell leads to an 
increase in ITC cell uptake.  
 
 
4.2.2 Distibution 
The term distribution means the path of a compound from the site of 
administration to the vessels and tissues. The parameters that 
influence the distribution of a compound in the body are: blood flow, 
the presence of membranes, the affinity for tissues and binding to 
plasma proteins, such as albumin and glycoproteins. Only the 
unbound  fraction to these proteins can pass through the membranes. 
Recently, some researchers  have developed a sensitive and 
appropriate method which allows the determination of low 
concentrations of ITC and metabolites in biological fluids and tissues 
(Ye et al. 2002). They observed that following a rapid absorption and 
appearance in plasma, the ITC peak levels (0.94 ± 2.27 mol L-1) from 
broccoli sprouts (especially sulforaphane), decrease. These data 
demonstrate a rapid distribution, which follows a first order kinetics 
with a half-life of 1.77 ± 0:13 hours (Ye et al. 2002).  ITC are 
transported in the blood bound to plasma proteins to which they bind 
strongly presumably by interaction with -SH groups, and only in small 
part, in free form. The distribution to tissues involves the passage of 
the compounds through the membranes and this follows the same 
uptake mechanism described for intestinal absorption. The driving 
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force for ITC passive diffusion across membranes is its conjugation 
with GSH. A study, carried out by administering to rats 14C ITC, 
revealed high levels of ITC in the stomach and intestine, intermediate 
concentrations are found in the pancreas and spleen and very low at 
the level of heart and brain (Conaway et al. 1999) .  
 
4.2.3 Metabolism 
The bioavailability of a compound, even if absorbed in high 
concentrations, may be limited by a rapid and extensive metabolism. It 
is therefore important to determine which are the metabolites of this 
compound and in what concentrations they are found in blood, urine 
or faeces.The GLS are not present in the faeces, therefore these 
compounds are subjected to an extensive metabolism. As already said, 
the GLS are hydrolyzed to ITCs by the myrosinase enzyme in the oral 
cavity as a result of liberation of the enzyme from the vegetable 
matrix, or at intestinal level by the microbiota. The first step in the 
metabolism of ITCs is the conjugation with GSH. It is not clear if this 
conjugation occurs in the duodenum during absorption, or in the liver, 
which is the site with the highest GST. Subsequently, the ITC 
conjugates are metabolized by different enzymes such as the 
glutamyltranspeptidase (GTP), the cysteinylglycinase (CGase) and N- 
acetyltransferase (NAT) that lead to the formation of the different 
metabolites shown in Figure 4-4.This sequence of reactions usually 
leads to the formation of mercapturic acid, a hydrophilic metabolite 
that can easily be excreted in the urine. 
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Figure 4-4: GLS metabolites 
The main metabolites of urinary excretion in humans are  N-acetyl 
cysteine conjugates (NAC) that are currently used as reliable 
biomarkers of exposure to GLS (Shapiro et al. 2001). 
 
4.3 Absorption of dietary ITC 
 
In agreement with the observation that ITC are readily absorbed and 
metabolized in vivo mainly through the way of the mercapturic acid 
and then excreted in the urine as NAC, numerous studies have shown 
that dietary intake of ITC can be assessed by measurement of the 
NAC conjugates in urine, which are then to be a reliable marker of 
exposure. 
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Ye et al.(2002) demonstrated in a study conducted on volunteers, that 
the intake of a single dose of broccoli extract sprouts containing 200 
µmol ITC, in which all  glucosinolates had been hydrolyzed and the 
majority of the ITC were constituted by SF. ITC were absorbed 
rapidly and reached a peak plasma concentration of 0.94-2.27 µmol/l, 
1 h after ingestion. The cumulative excretion of ITC equivalents at 8 h 
represented to 58.3 ± 2.8 % of the ingested dose (Ye et al. 2002). In a 
similar experiment the cumulative excretion of ITC equivalents after 
72 h was 88.9 + / -55 % of the dose. 
 
4.4 Bioavailability of dietary ITC 
Understanding of factors, affecting  the release of phytochemical 
components from the food matrix, their absorption and their fate in the 
body, is essential to determine the mechanism of action and biological 
effect. 
There are several factors that can influence ITCs and  GLSs : the plant 
variety, (Kushad et al. 1999; Mithen et al. 2001), agronomic and 
environmental factors such as soil and climatic conditions (Ciska et al. 
2000; Pereira et al. 2002; Vallejo et al. 2003), but also plant storage 
and technological processes before consumption and cooking. Cold  
storage can cause the loss of nearly 50 % of GLSs, while cutting 
promotes the hydrolysis only on the cut surface. So in intact broad 
leaves or in broccoli or cauliflower inflorescences there is  minimal 
GLS loss before cooking. If these vegetables are eaten raw, both intact 
GLS and active myrosinase are assumed simultaneouslyin the 
hydrolysis of GLS, occurs in the gastrointestinal tract. Some of the 
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GLS ingested are hydrolyzed in the colon by bacterial myrosinase, 
anyway myrosinase contained in the plant is the dominant factor. 
Assuming that there is a large loss of GLS in the cooking water 
(between 30 and 60%), due to their hydrophilicity, it is evident that 
the preparation method can make a big difference on the assumption 
of GLS and on bioavailability of their hydrolysis products. An 
important factor in determining levels of ITCs intake is the combined 
influence of the cooking and the microbiota in the intestinal tract : 
mild cooking conditions (less than 75-80 ° C) cause an increased 
production of ITCs allowing the release of myrosinase, but the 
myrosinase rapidly denaturates when the temperature reaches 90 ° C . 
The content of ITC in the initial preparation was about the same (1.1 
and 1.0 micromol /g wet weight), however, the urinary  ITCs 
excretion in 24h was 32.3 % for raw broccoli and 10.25 % for cooked. 
These results indicate that ITCs bioavailability  in raw vegetables, 
where the myrosinase had not been inactivated by heat, was three 
times higher (Conaway et al. 2000). Following  administration of 
broccoli sprouts extract containing only ITC (after complete 
hydrolysis) or GST alone (in which myrosinase had been completely 
inactivated), the cumulative urinary excretion of  ITC equivalents was 
to 80 % and 12 % of the dose  respectively in 72h (Shapiro et al. 
2001). These studies clearly show that plants in which myrosinase is 
still functional purchase  a quantity of  ITC amount much larger than 
those in which myrosinase is inactive. On the other hand different 
types of  Cruciferous vegetables including broccoli and cabbage form 
nitriles (no anticarcinogenic properties known) as hydrolysis products 
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of GLS (Bones et al. 2006; Matusheski et al. 2006).These Cruciferous 
vegetables contain a ESP-like protein (ESP) that appears to be 
responsible for the formation of epithionitriles. ESP a not only 
catalyzes  GLS hydrolisis, but also acts as a cofactor of myrosinase 
directing unstable products of hydrolysis to epithionitriles rather than 
to  ITC. The ESP is more thermolabile than myrosinase and therefore 
a bland and short heat treatment can lead to a high ITC production, 
since this renders inactive ESP leaving a certain amount of active 
myrosinase (Bones et al. 2006). It is also clear that the myrosinase 
activity , employed by the intestinal microbiota, can hydrolyze only a 
small fraction of ingested GLS. Nevertheless when the microbiota is 
reduced by a combination of mechanical removal and antibiotic 
therapy, there is a further reduction in the ITC urinary excretion in 
from 11.3 ± 3.1 % to 1.3 ± 1.3 % of the dose.  
 
 
4.5 Biological activities of sulforaphane 
SF induces a phase II detoxification response promoting a disruption 
of nuclear factor E2-factor related factor (Nrf2)-Kelch-ECH-
associated protein (Keap1) intereactions and mitogen-activated protein 
kinase activation. As a result, Nrf2 modulates gene expression via 
antioxidant response element (ARE). ARE-driven targets include 
NQO1, HO-1 and γ GCL and the induction of these enzymes has been 
observed both, “in vivo” and “in vitro” experiments after SF tratment. 
As we mentioned aboe, SF in contained in broccoli and this is the 
reason why several experiments have been done with dietary 
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ingenstion of this cruciferous vegetable. For example, dried broccoli 
sprouts (200mg/day) were able to attenuate oxidative stress, 
hypertension and inflammation in stroke-prone  spontaneusly 
hyertensive rats (Wu et al. 2004). In addition, the antihypertensive 
effect of broccoli sprouts was accompanied by an enhancement in the 
GSH concentration and in the activities of GPx and GR in hearts, 
kidney, aorta and carotid, and by decreasing the macrofage infiltration 
in inner intimal layers of the aorta, carotid artery and endocardium of 
the heart, as well as in the kidney medullary interstitium and 
tubules.These beneficial effects were associated to the supression of 
the NF-kB pathway (Wu et al. 2004). Later, a cardioprotective effect 
was found after feeding broccoli for 30 days to rats in isolated heart 
preparations submitted to ischemia and reperfusion (Mukherjee et al. 
2008). Rats feed with broccoli had an increased postischemic 
ventricular function and reduced myocardial infarct size along with 
reduced cardiomyocytes apoptosis. These protective effets were 
associated with a prevention in the decrease of thioredoxin, 
glutaredoxin and peroxiredoxin, HO-1, SOD1, SOD2 and Nrf2 as well 
as enhanced induction of the survival signalling proteins including 
Bcl-2, Akt, extracellular signal-regulated kinase ½, and down-
regulation of the proteins (Bax, Jnk, p38) of the death signalling 
pathways.  
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4.6 Protective effects of SF 
 
 4.6.1 Brain and neuronal injury 
Sulforaphane has a neuroprotective effects in several experimental 
paradigms. (Zhao et al. 2006) showed that a single SF administration 
was able to reduce the infarct size in rats induced by ischemia and 
reperfusion by increasing HO-1 espression in brain. It is important to 
noticethat HO-1 is an inducible enzymes that catabolizes free heme 
into carbon monoxide, iron and biliverdin, which is converted to 
bilirubin by biliverdin reductase. The same protective effect was 
observed in a neonatal hypoxia-schemia brain injury model (Ping et 
al. 2010) in which SF decreases malondialdehyde and 8-hydroxy-2-
deoxyguanosine levels. In addition, a model of oxugen and glucose 
deprivation in immature neurons and in astrocytes (Danilov et al. 
2009; Soane et al. 2010).  SF protects the cells activating  the 
Nrf2/ARE pathway, increases the gene trasciption protein levels and 
activity of antioxidant enzymes including NQO1, HO-1 and γGCL 
modifier subunit. Interestingly, SF also protects blood brain barrier 
after brain injury which was accompanied by the enhanced expression 
of Nrf2-driven genes (Zhao et al. 2007). SF njection protected against 
cerebral damage induced by instriatal injection of autologous blood 
(Zhao et al. 2007) and also activated Nrf2 brain tissue and reduced 
neutrophile count, oxidative damage, and behavioral deficits. Nrf2-
deficient mice showed more severe neurologic deficits and did not 
benefit from the protective effect of SF. The above described 
protection was not observed in mice lacking by Nrf2 gene and 
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suggesting that this protection was dependent of Nrf2 (Zhao et al. 
2007). In another brain experimental model, lipopolysaccharide-
induced inflammation was attenuated by SF pre treatment with Nrf2 
induction and HO-1 espression in the hippocampus of these animal 
brain (Innamorato et al. 2008). The role of Nrf2 in this protective 
effect was confirmed by using Nrf2 deficient mice. To add strength, 
“in vitro” studies have been done using SF and results also 
corroborate the protective SF effect and add more information about 
the mechanism of protection. For example, in BV2 microglial cells, 
the protective effect of SF against oxidative effect of 
lipopolysaccharide was associated with HO-1 induction (Innamorato 
et al. 2008). In another cell culture the dopaminergic cell death, 
induced by a compound that produces dopamine quinone: 6- 
hydroxydopamine and tetrahydrobiopterin, was also attenuated by SF 
preincubation (Han et al. 2007). These experiment demonstrated that 
SF pretreatment prevented membrane damage, DNA fragmentation, 
and ROS formation. SF, increased mRNA levels and enxymatic 
activity of NQO1 in a dose-dependent manner (Han et al. 2007). In 
another experiment model, SF protects cortical neurons against the 
neurotoxin 5-5-cysteildopamine damage, because SF induces the 
expression and the activation of Nrf2 and therefore increases the 
espression and activity of GST, GR and NQO1 (Vauzour et al. 2010). 
Interestingly, SF increases in time-concentration manner reduced GSH 
levels in dopaminergic-like neuroblastma SHSY-5Y cell line which is 
associated with its protective effect againsy hydrogen peroxide 
(Tarozzi et al. 2009). 
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4.6.2 Liver damage 
Baek et al.(2008) demostrated the protective effect of SF on carbon 
tetrachloride-induced liver injury in mice. They showed that SF 
ameliorated the carbon tetrachloride induced increase in the serum 
level of alanine amnotransferase, lipid peroxidation and necrosis. This 
hepatoprotective effect was associated with liver phase II enymes 
induction. In this sense Li iet al. (2010) have shown that SF 
upregulated the expression of the pi class of GST through the Nrf2 
pathway in rat Clone 9 liver celle. Moreover Razis et al. (2010) also 
demonstrated that R-SF is more effective a an inducer of the 
detoxifying enzymes system, in bothliver and lung, compared with the 
S-enatiomer. Finally Zhao et al.(2010) is investigated the effect of SF 
on regulation of  Nrf2/ARE pathway in liver injury induced by 
intestinal ischemia/reperfusion. They showed  that the pretreatment 
with SF ameliorates the ischemia-reperfusion induced intestinal and 
liver injury. This protection was associated to the increase in liver 
expression of Nrf2 and HO-1.  
 
4.6.4 Hyperglycemia 
Xue et al.(2009) demonstrated that treatment with SF in a human 
microvascualar HMEC-1 endothelial cells model incubated in lowand 
hignt glucose concentration can prevent ROS production, 
mitochondrial and biochemical dysfunction induced by hyperglycemia 
which was associated to increased expression of transketolase. Song et 
al.(2009) have found that SF pretreatment was able to ameliorate 
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streptozotocin-induced islet damage in mice. SF pretreatment was able 
to ameliorate hyperglycemia and decreased insulin blood 
concentration and to preserve the number of islets producing insulin. 
The protective effect of SF in streptozotocin induced diabetes was 
associated to the prevention of the induction of  NF-kB in islets of 
thee mice. Similar “in vitro” results were presented in rat pancreatic β-
cell line RINm5F, where SF preincubation was able to induce Nrf2 
traslocation into the nucleus and subsequnce gene expression of 
several cytoprotective enzymes including  γGCL (Song et al. 2009). In 
addition, preincubated pancreatic β cells with SF are resistant to the 
toxic effect of citokynes preventing H2O2 formation. SF also 
suppressed the increae in inducibile nitric oxide synthase induction 
and cyclooxygenase expression (Song et al. 2009). 
 
 
 
4.6.5 Damage to heart and cardiac cells 
Zhu et al.(2008) showed that the incubation of rat aortic smooth 
muscle A10 cells with different concentrations of SF induced in 
concentration –dependent manner the level and activity of antioxidant 
and phase II enzymes such as catalase, SOD, GPx, GR, GST, NQO1 
and GSH. SF can also induce the expression and the activity of 
catalase, GSH, SOD and GST in isolated mitochondria of aortic 
smooth muscle cells. In the same study, the pretreatment of SF 
prevented the cell death, ROS production and oxidative cytotoxicity 
by xanthine oxidase/xanthine and H2O2. It’s has been demonstrated  
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that SF increased the gene expression, protein expression and enzyme 
activity of phase II enzymes including GR, GST, NQO1, TRr in 
cultured rat neonatal cardiomyocytes model (Angeloni et al. 2009). 
These increases were in time-concentration manner. SF pretreatment 
was able to avoid the cell death, ROS production and DNA 
fragmentation induced by H2O2 in cardiomyocytes. On the other hand, 
SF prevented the ischemia-repurfusion injury in hearts (Piao et al. 
2009). The protective effect was observed by an inhibition of the 
increase in the post-ischemic left ventricular end-diastolic pressure 
and improved the post-ischemic left ventricular developed pressure 
coronary flow  reduction in the infracted area and decreased lactate 
dehydrogenase levels during reperfusion. SF prevented the decrease in 
protein expression of some antioxidants enzymes including catalase, 
Mn-SOD and HO-1. 
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CHAPTER 5 
 
5. Aim   
 
Chronic degenerative diseases represent the main cause of mortality in 
the industrialized world. A common determiner of these pathology is 
oxidative stress, a great imbalance between reactive oxygen species 
and antioxidant defences with resulting damages to biological 
macromolecules. In the last years, many studies have directed their 
attention to carbonyl stress, a condition wherein there is an imbalance 
between pro-glycant species production and organism defences to 
glycation. Carbonyl stress is probably responsible of Alzheimer 
disease, renal dysfunctions and cardiovascular diseases. It was 
observed that after ischemic stroke there is an increase of oxidative 
stress, to which are associated several troubles. It’s very important to 
remember that the antioxidant enzymes activity in the heart is lesser 
than other organ. For this reason the heart is more susceptible to 
oxidative stress. Therefore, any mechanisms, able to increase 
antioxidant defences, result fundamental to protect cardiac cells from 
damages induced by oxidative stress. In 1986 Murry et al. (Murry et 
al. 1986) described ischemic preconditioning (PC) as a phenomenon 
whereby myocardium exposed to brief episodes of ischemia and 
reperfusion develops protection against irreversible injury during a 
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subsequent ischemic insult. This phenomenon has been recognized as 
the strongest form of in vivo protection against myocardial ischemic 
injury (Kloner et al. 1998). In experimental animals, a brief period of 
ischemia usually produces two windows of protection: an early phase 
which develops very quickly and lasts only 1-2 h, and a late phase that 
develops after 12-24 h but lasts 3-4 days (Kloner et al. 2001; Eisen et 
al. 2004). The early phase develops by rapid post-translational 
modification of pre-existing protein through a series of signaling 
cascades, while late (or delayed) ischemic PC is mediated by 
cardioprotective gene expression and by synthesis of new 
cardioprotective proteins (Rizvi et al. 1999; Das et al. 2008).  
The ischemic PC concept has also been extended to PC triggered by 
non-ischemic stress, such as stretch, some chemicals (Shattock et al. 
1993), and reactive oxygen species (ROS) (Leon et al. 1998). Redox 
signaling in PC is still not completely understood, but it is widely 
accepted that transient, low concentrations of ROS and/or reactive 
nitrogen species (RNS) may trigger protective mechanisms. Some 
ROS (i.e. O2− and H2O2) and RNS (i.e. NO, HNO, ONOO−) may be 
included among the triggers of PC, and it is likely that they 
collaborate in inducing cardioprotection (Penna et al. 2009). Recently, 
the role of H2O2 as PC inducer in the protection against different 
forms of damage has received attention. Sharma et al. (2001) have 
observed that H2O2 induced PC may provide cardioprotection, similar 
to ischemic PC, against ischemia–reperfusion injury in isolated rat 
heart. In a mouse L-cell model, H2O2 PC protected cells against 
apoptosis induced by subsequent oxidative stress via MAPK and 
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PI3K/Akt pathways (Han et al. 2001). In addition, H2O2 PC has been 
shown to protect human proximal tubular cells against lethal oxidant 
insult via p38 MAPK and heme oxygenase-1 (Lee et al. 2003). In 
more recent studies, it has been demonstrated that H2O2 PC protects 
PC12 cells against apoptosis induced by oxidative stress through 
different mechanisms: blockade of reductions in mitochondrial 
membrane potential, overexpression of Bcl-2 (Tang et al. 2005) and 
inducible nitric oxide synthase and cyclo-oxygenase-2 (Tang et al. 
2006), and activation of the Janus kinase (JAK)-signal transducer and 
activator of transcription (STAT) pathway (Yu et al. 2006), and 
increase in the DNA binding activity of NF-kB p65, as well as its 
nuclear translocation (Zhang et al. 2009).  
Another strategy to protect cardiac cells from oxidative damage is an 
up-regulation by natural or synthetic chemical inducers, of 
endogenous antioxidants and phase II enzymes of xenobiotic 
metabolism (Cao et al. 2006). The main effect of this induction would 
be a reinforcement of antioxidant cellular capacity.  Among them, 
sulforaphane is one of the most promising diet-derived indirect 
antioxidant agents. SF is produced by the breakdown of 
glucoraphanin, a glucosinolate abundantly present in some 
Cruciferous vegetables, especially broccoli.  It has been reported that 
broccoli protects hearts against I/R injury through the redox cycling of 
the thioredoxin superfamily (Mukherjee et al. 2008). We have 
demonstrated that SF protects cardiomyocytes against apoptosis 
induced by oxidative stress (Angeloni et al. 2009). In a recent study 
we have also identified that SF modulate other molecular targets such 
89 
 
as GLO1. GLO1, GLO2 enzymes and a catalytic quote of reduced 
GSH  form the glyoxalase system. This system catalyze the 
conversion of  α-ossoaldeidi in α-idrossiacidi. This allow the 
biotransformation of toxic compound for the cell, such as 
methylglyoxal, in no toxic compound, D-lactate.  Glyoxalase system 
represent a detoxifying system to dicarbonyl species, and so, as an 
integral part of organism antioxidant defences. This is also 
fundamental to limit the toxicity induced by carbonyl stress, apoptosis 
and AGEs formation. AGEs are an heterogeneous group of molecules 
that are generated through a non-enzymatic glycation and oxidation of 
proteins, lipids and nucleic acids (Thorpe et al. 2003).  A great 
presence of AGEs at cellular level, is related with Alzheimer 
,Parkinson and cardiovascular  disease.  Previous studies have been 
shown that the glycation generate the AGEs production on β-amyloid 
plaque (Chen et al. 2006), that MG is the main glycant agent in this 
process (Webster et al. 2005). These observations have  suggested that 
AGEs can promote the depositing of  β-amyloid and plaques in brain 
with AD.  The glyoxalase system was related with chronic pathology 
induced by oxidative stress or hyperglycemias. In particular a decrease 
of GLO1enzymtic activity in situ caused by ageing and oxidative 
stress increase the glycation. The oxidative stress is bound  glycation 
because the depletion of GSH cause a decrease of GLO1 enzymatic 
activity and an increase of methylglyoxal and glyoxal. 
The aim of this thesis was evaluated molecular mechanisms in 
cardio- and neuroprotection and the possibility of modulation by 
nutraceutical phytocomponents.   
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CHAPTER 6 
 
6. Materials and Methods  
 
6.1 Materials 
PhosSTOP was purchased from Roche Diagnostics (Mannheim, 
Germany). CelLytic M, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT), 2’,7’-dichlorodihydrofluorescein 
diacetate (DCFH-DA), H2O2, fetal bovine serum (FBS) , mammalian 
protease inhibitor mixture,  glucose-6-phosphate, glucose-6-phosphate 
dehydrogenase, bovine serum albumin, NADP, dimethyl sulfoxide 
(DMSO), 2,2-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) 
(ABTS), glutamine, penicillin-streptomycin,  reduced glutathione 
(GSH), 2 LY 294002 (LY), PD 98059 (PD), SB 203580 (SB), DMEM 
F12, DMEM, fetal caw serum (FCS), horse serum (HS), Gentamicin, 
Amphotericin B, acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin 
(Ac-DEVD-AMC), 7-amino-4-Methylcoumarin (AMC), trypsin, and 
all other chemicals of the highest analytical grade were purchased 
from Sigma Chemical Co. (St. Louis, MO, USA).  3,8-
phenanthridinediamine, 5-(60-triphenylphosphoniumhexyl)-5,6 
dihydro-6-phenyl (MitoSOX) was purchased from Invitrogen (Paisley, 
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UK). Dihydroethidium (DHE) was purchased from Molecular Probes 
(Eugene, OR,USA). 
6.2 Cells line 
Neonatal Wistar rat cardiomyocytes were isolated as reported (Hrelia 
et al. 2002). Briefly, cells were obtained by isolation of 
cardiomyocytes from the ventricles of 2–4 days old Wistar rats, 
seeded at a density of 1x105 cells/cm2 and grown until confluence in 
DMEM F12 supplemented with 10% v/v FCS, 10% v/v HS, 1% v/v 
gentamicin, 1% v/v Amphotericin B and 1% v/v sodium pyruvate and 
incubated at 37C° in 5% CO2 humidified atmosphere. 
The human neuroblastoma cell line SHSY-5Y was purchased from 
Sigma Chemical Co. (St.Louis, MO, USA). The cells  were grown in 
DMEM medium supplemented with 10% v/v heat inactivated FBS, 
1% v/v 200mM gentamicin and 1% v/v penicillin-streptomycin. 
 
6.3 Preconditioning, oxidative stress, carbonyl  
      stress and SF treatment 
PC was simulated with different concentration of H2O2 (1µM, 5µM, 
10µM, 50µM and 100µM) for 10 minutes.  
Oxidative stress was induced by exposing the cells to H2O2 100µM for 
30 minutes. 
Carbonyl stress was induced by exposing cardiomyocytes to MG 
1mM for 24 hours and SHSY-5Y to MG 0.5mM for 24 hours 
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Cells were treated with 5 µM SF for different time points, and control 
cells were treated with equivalent concentrations of DMSO alone. SF 
concentration utilized in this study is readily achievable in rat and 
human plasma (Hu et al. 2004; Gasper et al. 2005). 
 
6.4 Cell viability assay 
Cell viability was evaluated by measuring MTT reduction. At the end 
of each experiments, MTT was added to the cell medium (final 
concentration 0.5 mg/mL) and incubated for 1 h at 37° C. After 
incubation, MTT solutions were removed, DMSO was added and the 
absorbance was measured using a microplate spectrophotometer 
(VICTOR3 V Multilabel Counter, Perkin Elmer e Wellesley, MA, 
USA) at a wavelength of 595 nm.  
 
6.5 Caspase-3 activity assay 
The activity of caspase 3 was measured by hydrolysis of the peptide 
substrate Ac-DEVDAMC by caspase 3, resulting in the release of the 
fluorescent 7-amino-4-methylcoumarin moiety (Nicholson et al. 
1995). Cells were lysated in lysis buffer (50 mM Tris, 0.1% Triton X-
100, 150mM NaCl, 2mM EGTA/EDTA, 1mM sodium pyrophosphate, 
10 mg/mL phenylmethylsulfonyl fluoride, 1 mM sodium vanadate, 50 
mM sodium fluoride, 1 mg/mL aprotinin and then centrifuged 5 min at 
5000 g. From each sample, 5µl was transferred to a 96-well plate and 
200µl of reaction mix (20 mM HEPES pH 7.4, 0.1% CHAPS, 5mM 
DTT and 2mM EDTA) containing Ac-DEVDAMC (final 
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concentration 16 µM), was added to each well. Fluorescence intensity 
was recorded every 5 min for 1 h by amicroplate spectrofluorometer 
(λex/em= 360/460 nm). Caspase activity was calculated using a AMC 
standard curve and results were expressed as nmol AMC/min/mg 
protein. 
 
6.6  Detection of intracellular ROS production  
• Confocal microscopy: ROS formation in cardiomyocytes was 
visualized as follows. Cells were incubated with 5 µM SF for 24 
h, exposed to1 mM MG for 24 h, and then washed twice with 
warm PBS, and DHE and MitoSOX were added to cells at a 
final concentration of 5 µM. After incubation with DHE 
(20min) and MitoSOX (10 min), cells were fixed with 4% 
paraformaldehyde for 10 min, mounted onto glass slides with 
Mowiol, and observed under a confocal microscope with 
excitation and emission wavelengths set to 490 and 590 
nm,respectively (Marella et al. 2007; White et al. 2008). All 
images were taken under identical exposure conditions in order 
to evaluate the intensity of the probe fluorescence accurately. 
Confocal imaging was performed on a Nikon A1 confocal laser 
scanning microscope as previously described (Resca et al. 
2013). The confocal serial sections were processed with ImageJ 
software to obtain three-dimensional projections, as previously 
described (Maraldi et al. 2013). The image rendering was 
performed by Adobe Photoshop software. 
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• Spectrofluorimetric assays: ROS production was evaluated 
using different fluorescence probe: DCFH-DA, DHE and 
MitoSOX. At the end of treatment cells were washed with PBS 
and then incubated with 5 µM DCFH-DA for 30 min. Next, 
cells were incubated with 1mM MG. Cell fluorescence was 
measured using a microplate spectrofluorometer (VICTOR3 V 
Multilabel Counter) (λex/em=485/535nm) as previously 
reported (Bradford 1976). Cells were treated with 5 µM SF for 
24 h and then exposed to 1 mM MG. Cells were washed with 
PBS and incubated with 5 µM DHE for 20 min or 5µM 
MitoSOX for 10 min at 37 °C. Cell fluorescence was measured 
using a microplate spectrofluorometer (VICTOR3 V Multilabel 
Counter) (λex/em=485/590nm). 
 
• Total antioxidant activity (TAA): TAA assay, performed as 
previously reported (Bordoni et al. 2005), was used as an 
indirect index of intracellular ROS production. Briefly, at the 
end of each experiment, cardiomyocytes were washed 3 times 
with cold PBS. Cells were lysated in PBS using a potter 
homogeniser and centrifuged at 1000g to remove cell debri. 
TAA was determined by the decoloration of the radical cation 
ABTS, in terms of quenching of absorbance at 740nm. Values 
obtained for each sample were compared with the 
concentration– response curve of a standard Trolox solution, 
and espresse as µmol of Trolox Equivalent Antioxidant Activity 
per mg of protein (TEAA µmol/mg protein). 
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6.8 Western blotting 
Preparation of nuclear and cytoplasmic fractions were performed 
according to the method of  (Bahia et al. 2008) and whole-cell extracts 
with CelLytic TMM Cell lysis reagent, with mammalian protease 
inhibitor mixture and PhosSTOP. Samples were boiled for 5 min prior 
to separation on 10% SDS-PAGE. The proteins were transferred to a 
nitrocellulose membrane (Hybond-C; GE Healthcare, 
Buckinghamshire, UK) in Tris-glycine buffer at 110 V for 90 min. 
Membranes were then incubated in a blocking buffer containing 5% 
(w/v) skimmed milk and incubated with anti-GST (Alpha Diagnostic 
International, San Antonio, TX, USA), anti-GR (AbFrontier, Seoul, 
Korea), anti-TRred (Upstate, Lake Placid, NY, USA), anti-GPX1 (Lab 
Frontier, Seoul, Korea), anti-NQO1, anti-SOD1, anti-SOD2, anti-
CAT, anti-Nrf1, anti-Nrf2, anti-GLO1 (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA), anti-phospho-p38, anti-phsopho-ERK1/2, 
anti-phosho-Akt, anti-Bcl2, anti-Caspase 3 (Cell Signaling 
Technology, Beverly, MA, USA), and anti-β-actin (SIGMA) and anti-
Histone H3 (Cell Signaling Technology), as internal normalizers, 
overnight at 4°C on a three-dimensional rocking table. The results 
were visualized by chemiluminescence using ECL® Advance reagent 
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according to the manufacturer's protocol (GE Healthcare). 
Semiquantitative analysis of specific immunolabeled bands was 
performed using a Fluor S image analyzer (Bio-Rad, Hercules, CA, 
USA). 
 
6.9 Enzymatic activity assays 
NAD(P)H quinone oxidoreductase 1 (NQO1) enzymatic activity was 
measured according to the procedure of  Prochaska et al. (1988). 
Glutathione S-transferase (GST) activity was assayed according to the 
procedure of  Habing et al. (1974). Thioredoxin reductase (TRred) 
activity was assayed according to the procedure of Holmgren and 
Bjornstedt (1995). Glutathione reductase (GR) activity was measured 
according to the method of  Smith et al. (1988). Glutathione 
peroxidase (GPX) activity was assayed according to the method 
described by Flohe et al. (1984). Catalase (CAT) activity was 
determined according to the method of Johanssonet al. (1988). 
Superoxide dismutase (SOD) activity was measured according to the 
method of  Peskin et al.(2000). Glyoxalase 1 (GLO1) activity was 
measured according to the method of Mclellan anf Thornalley  (1989). 
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6.10 AGE assay 
AGE protein adducts were quantified by the OxiSelect™ AGE ELISA 
Kit (Cell Biolabs, San Diego, CA, USA) according to manufacturers’ 
instructions 
 
6.11Detection of reduce GSH level 
Reduce GSH level was evaluated using a thyole reactive dye 
monochlorobimane (MCB) which is essentially non-fluorescent until 
it reacts with GSH to form a fluorescent GSH-MCB conjugate (Rice 
et al. 1986). At the end of treatments, cells were incubated with 50µM 
MCB in HBSS for 30 minutes. Cell fluorescence was measured using 
355 excitation and 460nm emission with a microplate 
spectrofluorometer  (VICTOR 3 VTM Multilabel Counter) 
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6.12 Small-interfering RNA transfection  
Cardiomyocyteswere transfected with 50 nM Nrf1- and Nrf2-annealed 
small interfering (si)RNA (Invitrogen, Pisley, UK) using 
Lipifectamine 2000 for 12 h according to manufacturer’s 
recommendations. The siRNA sequences utilized targeted the 
following rat Nrf1 coding sequences: 5’-
GACUUCUUGGACAAGCAGAUGA-3’ and 5’-
UCAUCUGCUUGUCCAAGAAGUCAGC-3’ and the following rat 
Nrf2 sequences: 5’-UGGAGCAAGACUUGGGCCACUUAAA-3’ 
and 5’-UUUAAGUGGCCCAAGUCUUGCUCCA-3’. Control 
expriments were formed using equivalent amounts of the StealthTM 
RNAi Negative Control Med GC (Invitrogen).. 
 
6.13 Protein concentration 
The protein concentration of the cell lysates was determined by the 
Bio-Rad Bradford protein assay (Bio-Rad Laboratories, Hercules, CA, 
USA). 
 
6.14 Statistics 
Each experiment was performed at least three times, and all values are 
represented as means ± SD. One-way analysis of variance (ANOVA) 
was used to compare differences among groups followed by Dunnett’s 
or Bonferroni’s test (Prism 5, GraphPad Software Inc., San Diego, 
CA, USA). Values of p<0.05 were considered as statistically 
significant. 
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CHAPTER 7 
 
7 RESULTS 
 
7.1 Protective effects of H2O2 preconditioning 
     Against oxidative stress in cardiomyocytes 
 
7.1.1 Preconditioning protective effect 
First objective of this thesis was to determine the concentrations of  
H2O2 able to simulate ischemic preconditioning (PC) in vitro. 
Cardiomyocytes were treated with different concentrations of  H2O2 
(1, 5, 10, 50, 100 µM ) for 10 min (preconditioning) and after 24 h 
were subjected to oxidative stress induced by hydrogen peroxide 100 
µM for 30 min. Cell viability was assessed by MTT assay 24 h after 
oxidative stress. 
In cells not preconditioned, oxidative stress determined a significant 
reduction of cell viability of about 50 % (Fig.7-1). Treatments with 1-
10 µM H2O2 did not show any protective effects against oxidative 
stress, meanwhile 50 and 100 µM H2O2 were able to significant 
increase cell viability in respect to cells exposed to oxidative stress. 
Interestingy, treatment with 100 µM H2O2 increased cell viability to 
values comparable to control cells. 
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Figure 7-1: Effect of H2O2 preconditioning (PC) on cell viability in 
cardiomyocytes exposed to oxidative stress. Cells were treated with  increasing 
concentrations of H2O2 (1-100 µM) for 10 min. After 24 h, cells were stressed 
with 100 µM H2O2 for 30 min and cell viability was assessed by the MTT assay 
and reported as %cell viability compared with controls .Each bar represents 
means ± SD of 4 independent experiments. Data were analyzed by one-way 
ANOVA followed by Bonferroni’s test: *p< 0.05 vs Control; °p< 0.05 vs 0 
(Stressed cells) 
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Ischemic PC is a phenomenon that has a biphasic pattern characterized 
by two different time windows of protection: a first phase of 
protection ( or first window of protection) that develops immediately 
and disappears within 1-2 hours after the induction of PC (VanWinkle 
1991) and a second phase of protection (or second window of 
protection) that occurs 12 hours later by the induction of the PC and 
lasts for 72-96 hours (Marber et al. 1993). To understand if the main 
contribute of H2O2 PC is in the early or delayed PC, cells were 
preconditioned with H2O2 and stressed after different time from the 
induction of PC (1–72 h). Data reported in figure 7-2 show that after 1 
and 2 h from PC cell viability was significantly higher than that 
measured in not preconditioned cells. After 24 h from PC, cells are 
able to counteract oxidative stress damage with the highest efficiency 
maintaining cell viability at value comparable to control cells.After 48 
and 72 h from PC, H2O2 is still able to counteract oxidative stress 
injury but to a lesser extent than after 24 h from PC. These results 
suggest that H2O2 PC exerts its cardioprotectivea ction mainly in the 
late phase of PC. 
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Figure 7-2: Cell viability of cardiomyocytes subjected to H2O2  PC and 
oxidative stress at different times. Cells were treated with 100 µM H2O2 for 10 
minutes and recovered for different times periods (1-72 h) before the induction of 
oxidative stress. Cell viability was assessed by the MTT assay and reported as % 
cell viability compared with controls. Each bar represent  means ± SD of 4 
independent experiments. Data were analyzed by one-way  ANOVA followed by 
Bonferroni’s test: *p< 0.05 vs Control cells; °p< 0.05 vs 0 (Stressed cells) 
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To better understand  the role of  H2O2-PC against oxidative stress, we 
evaluated its effect against apoptosis. Apoptosis was assessed by flow 
cytometry, caspase-3 activity  and Bcl2 protein levels (Fig.7-3).  
Cell were preconditioned with H2O2 100 µM and after 24 h were 
exposed to oxidative stress. 
Cytofluorimetric assay (figure 7-3 A) revealed that H2O2-PC protected 
cardiomyocytes against apoptosis induced by oxidative stress. H2O2-
PC alone did not influence the percentage of apoptotic/necrotic cells 
in respect to controls, while oxidative stress induced a marked shift of 
the population from viable cells to early and late apoptotic cells. 
Preconditioning before oxidative stress was able to reduce the shift of 
cells from the viable to the apoptotic region in respect to oxidative 
stress alone. 
To further demonstrate the protection of 100 µM H2O2-PC against 
apoptosis, the activity of caspase-3, a key enzyme required for the 
execution of apoptosis, was measured. The activation of this enzyme 
represents a consolidated biomarker of apoptotic death. Cell were 
preconditioned with 100 µM H2O2 and after 24 h were exposed to 
oxidative stress (Fig.7-3 B). PC alone had no significant effect on 
caspase-3 activation. Oxidative stress significantly increased caspase-
3 activity in cardiomyocytes, while H2O2-PC significantly reduced 
caspase-3 activity induced by oxidative stress. 
One of the major genes responsible for regulating apoptosis is the 
proto-oncogene Bcl-2 localized to the nuclear membrane, endoplasmic 
reticulum and the outer mitochondrial membrane. It has been 
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demonstrated that Bcl-2 protein plays an anti-apoptotic role in  cardiac 
cells. We evaluated the expression of Bcl2 in preconditioned 
cardiomyoctytes after different time points from PC (figure 7-3 C). 
Immediately after H2O2 PC induction, Bcl2 expression was 
significantly increased compared with control cells and this induction 
lasted until 24 h from H2O2 PC. At 48 and 72 h from PC, Bcl2 
expression was comparable to control cells.  
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Figure 7-3: Effect of H2O2-
PC on apoptosis. Apoptosis 
was assessed by flow 
cytometry (A), caspase-3 
activity (B), and Bcl2 
protein levels (C). A: 
cardiomyocytes were 
preconditioned with 100 
µM H2O2 for 10 min and 
after 24 h were exposed to 
oxidative stress and flow 
cytometry was assesd using 
annexin  
V-phycoerythrin (PE)/7-
amino-actinomycin D (7-
AAD) described in the 
Materials and Methods 
chapter. B: caspase-3 
activity was measured 
spectrofluorimetrically in cell lysates as reported in METHODS. Each column represents 
the means ± SD of 4 independent experiments. Data were analyzed by one-way ANOVA 
followed by Bonferroni’s test. *P _ 0.05, with respect to control; °P _ 0.05, with respect to 
stress. Cardiomyocytes were exposed to H2O2 100 µM  for 10 minutes and lysates were 
obtained at different times after induction of the PC. Proteins were subjected to SDS-PAGE 
electrophoresis,s separated on the gel and transferred to nitrocellulose, incubated with anti-
Bcl2 antibody and detected by chemiluminescence as described in the Materials and 
Methods chapter. Anti β-actin were used as controls charcing. Densitometric analysis was 
performed on three separate nitrocellulose membranes. The data are reported as an 
increase compared to the control ± SD. The statistical analysis was performed with the test 
one-way ANOVA followed by Dunnet test: *p< 0.05 vs Control cells 
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7.1.4 Effect of H2O2 PC on intracellular ROS production 
Intracellular ROS production was measured to study the involvement 
of PC in modifying intracellular redox state. Cardiomyocytes were 
treated with different concentrations of  H2O2 and after 24 h were 
exposed to oxidative stress (Fig.7-4). Treatment with 1-10 µM H2O2 
did not influence ROS levels compared to cells not treated and 
exposed to oxidative stress (control+). On the contrary, 50 and 100 
µM H2O2 were able to significantly reduce ROS production compared 
to control+, in agreement with the data obtained with the MTT assay. 
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Figure 7-4: Preconditiong effect on the intracellular ROS production.  Cells 
were preconditioned with 1-100 µM H2O2  and after 24 h recovery were exposed 
to oxidative stress. Iintracellular reactive oxygen species was assessed by DCFH-
DA assay and values  represent  means ± SD  of 6 independent experiments. Data 
were analyzed by one-way ANOVA followed by Dunnet test: *p< 0.05 vs 
Control+ 
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7.1.5 Effect of H2O2 PC on antioxidant/phase II enzyme  
         induction and activity 
As H2O2 can not act as an antioxidant and its major protective effect is 
after 24 h from PC, we assumed that H2O2 PC antioxidant capacity 
could be ascribed to its ability to enhance the endogenous antioxidant 
defense system through the synthesis of new cardioprotective proteins. 
We therefore analyzed protein expression and activities of the main 
antioxidant and phase II enzymes: glutathione reductase (GR), 
thioredoxin reductase (TR),  NAD(P)H quinone oxidoreductase 1 
(NQO1), glutathione S-transferase (GST), glutathione peroxidase 
(GPX),catalase (CAT) and superoxide dismutase (SOD).  
Cardiomyocytes were preconditioned with different concentrations of 
H2O2 (1-100 µM) for 10 minutes and protein expression was evaluated 
after 24 h by immunoblotting.  
SOD1, SOD2, GPX, and GST expressions were not influenced by 
H2O2 PC at any tested concentrations (data not shown). On the other 
hand, GR, NQO1, and TRred expressions were significantly increased 
by 50 and 100 µM H2O2 PC, while CAT expression revealed a 
significant increase only at the highest H2O2 concentration (Fig.7-5). 
1-10 µM H2O2 did not modify protein level in respect to controls . In 
contrast, the concentration of 50 µM induces significantly GR, TR and  
NQO1, while the concentration 100 µM was able to induce , in 
addition to GR, TR and NQO1 also CAT, GST, GPX, while SOD was 
not affected PC. 
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To evaluate whether protein expression modifications were related to 
functional effects, enzyme activities were measured in the same 
experimental conditions. SOD, GPX, and GST activities were not 
modulated by H2O2 PC in respect to control cells (Table 7.1). In 
agreement with expression data, GR, NQO1, and TRred activities 
were significantly increased by 50 and 100 µM H2O2 treatment, while 
CAT activity was increased only by100 µM H2O2 PC.   
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Figure 7-5: Preconditiong effect on the induction of antioxidant phase II 
enzymes.  Cardiomyocytes were preconditioned with H2O2 1-100 µM  for 10 
minutes. Cell lysates (20µg) were immunoblotted with antibodies that detect 
endogenous levels of glutathione reductase (GR), catalase (CAT), thioredoxine 
reductase (TRred), and NAD(P)H quinone oxidoreductase 1 (NQO1). Results of 
scanning densitometry analysis permorfed on 3 independent antoradiograph are 
presented. Relative amounts (means ± SD) were normalized to the intensity of the 
same β-actin blot and represented as fold increase in respect to control. Data 
were analyzed by  one-way ANOVA followed by Dunnet’s test: *p< 0.05 vs 
Control cells 
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Table 7.1: Effects of different concentrations of H2O2 for 10 min on SOD, GPX, 
GST, GR, TRred, CAT, and NQO1 activities. 
µM 
H2O2 
SOD  
(U/mg 
protein) 
GPX 
(mU/mg 
protein) 
GST 
(nmol/min
/mg 
protein) 
GR 
(mU/mg 
protein) 
TRred  
(mU/mg 
protein) 
CAT 
(nmol/min/
mg 
protein) 
NQO1 
(noml/min/
mg 
protein) 
0 2.20±0.17 48.70±3.06 11.29±0.68 10.92±1.18 52.72±1.22 39.12±2.73 10.17±1.54 
1 2.23±0.16 54.98±3.43 10.96±0.64 10.98±0.47 53.47±5.98 41.93±4.80 10.30±1.30 
5 2.22±0.19 54.80±5.72 11.02±0.47 11.40±0.68 50.46±2.73 40.17±3.75 9.86±2.42 
10 2.30±0.14 53.13±10.11 10.03±0.54 10.43±0.26 53.84±6.07 37.17±5.44 12.99±3.98 
50 2.33±0.16 51.06±5.00 11.07±1.11 14.19±0.78* 60.65±2.83* 43.37±1.88 18.16±2.85* 
100 2.35±0.05 53.58±1.43 11.89±0.63 14.48±0.36* 76.77±5.94* 63.87±5.54* 20.38±2.85* 
 
*Value represents the mean ± SD of four independent experiments. 
Cardiomyocytes were preconditioned with 1-100 µM H2O2 for 10 min, and after 
24 h cells were lysed for enzymatic activity measures. GPX, glutathione 
peroxidase; GST, glutathione S-transferase; GR, glutathione reductase; TRred, 
thioredoxine reductase; CAT, catalase; NQO1, NAD(P)H quinone oxidoreductase 
1. Data were analyzed by one-way analysis of variance (ANOVA) followed by 
Dunnett’s test. * p<0.05 with respect to 0 µM H2O2 (Control) 
 
 
7.1.6 Effect of H2O2 PC on Nrf1 and Nrf2 activation. 
It has been shown that the expression of antioxidants and phase II 
enzymes is modulated by Nrf1 and Nrf2 thorugh the ARE/keap1 
pathway (Brigelius-Flohe et al. 2006; Purdom-Dickinson et al. 2007; 
Zhu et al. 2008) . Therefore,  we evaluated the effect of PC on Nrf1 
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and Nrf2 nuclear traslocation after different times from PC induction 
by analyzing both cytosolic and nuclear fractions (Figure 7-6 and 7-7). 
Results showed that PC induces Nrf2 translocation from the cytosol to 
the nucleus (Fig. 7-6). Indeed, Nrf2 expression in the nuclear fraction 
after 2 h from PC is significantly higher than that observed in control 
cells. In contrast, Nrf2 protein level in the cytosolic fraction decreases 
significantly after 0-3 h after PC, reaching levels similar or higher 
than those observed in control cells 6-24 h after PC induction. 
In a similar way, Nrf1 is translocated from the cytosol to the nucleus 
following PC (Figure 7-7). Nrf1 protein level in the nuclear fraction is 
significantly higher than that observed in control cells already after 1 
h after PC, while Nrf1 protein level in the cytosolic fraction decreases 
slightly after 2 h from the PC. 
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Figure 7-6: Preconditioning effect on the Nrf2 activation. Proteins were 
extracted at the indicated time points following H2O2 PC treatment. Crude 
homogenates (20µg) were immunoblotted with antibodies that detect endogenous 
Nrf2 levels in the cytosolic and nuclear fractions. Results of scanning 
densotometry analysis permormed on 3 independent autoradiograph are 
presented. Relative amounts (means ± SD) were normalized to the intensity of  β-
actin (cytosolic fraction) or histone H3 (nuclear fraction) and represented as fold 
increase in respect to control. Data were analyzed by  one-way ANOVA followed 
by Dunnet’s test: *p< 0.05 vs Control cells 
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Figure 7-7: Preconditioning effect on the Nrf1 activation. Proteins were 
extracted at the indicated time points following H2O2 PC treatment. Crude 
homogenates (20µg) were immunoblotted with antibodies that detect endogenous 
Nrf1 levels in the cytosolic and nuclear fractions. Results of scanning 
densotometry analysis permormed on 3 independent autoradiograph are 
presented. Relative amounts (means ± SD) were normalized to the intensity of  β-
actin (cytosolic fraction) or histone H3 (nuclear fraction) and represented as fold 
increase in respect to control. Data were analyzed by  one-way ANOVA followed 
by Dunnet’s test: *p< 0.05 vs Control cells 
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7.1.7 Effect of Nrf1 and Nrf2 silencing on H2O2 PC 
         induction of phase II enzymes. 
To clarify the role of Nrf1 and Nrf2 in the induction of phase II 
enzymes in preconditioned cardiomyocytes, cells were transfected 
with  Nrf1-siRNA and Nrf2 -siRNA, and scrambled control siRNA, 
and protein expression levels were determined 48 h posttransfection 
by Western blot analysis. Both Nrf1-siRNA and Nrf2-siRNA were 
able to strongly downregulate Nrf1 and Nrf2 (Figure 7-8 A) 
In cells transfected with Nrf1-siRNA and Nrf2 -siRNA was evaluated 
the effect of PC on the induction of phase II enzymes (Figure 7-8 B). 
Cells were transfected and after 48 h were preconditioned with H2O2 
100 µM. Proteins were extracted 24 hours after PC induction. It’s 
interesting to note that  the down-regulation of both Nrf1 and Nrf2  
determines a marked reduction NQO1, CAT, GR and TRred protein 
level compared to non- silenced and preconditioned cells. 
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Figure 7-8: Role of Nrf1 and Nrf2 in H2O2 PC-induction of phase II enzyme.  
A)effect of Nrf1-small interfering (si)RNA and Nrf2-siRNA on Nrf1 and Nrf2 
expression. Cardiomyocytes were transfected with 50 nM Nrf1-siRNA and Nrf2-
siRNA and after 48 h cell lysates were immunoblotted with antibodies for Nrf1 
and Nrf2 and β-actin. Representative immunoblots of 3 differentexperiments are 
reported. B) effect of Nrf1-siRNA and Nrf2-siRNA on NQO1, CAT, GR and TRred 
expression. Cardiomyocytes were transfected with 50 mM Nrf1-siRNA and Nrf2-
siRNA 48 h before H2O2 PC. Cell lysates were immunoblotted with antibodies for 
NQO1, CAT, GR, TRred and β-actin. Representative immunoblots of 3 different 
experiments are reported. 
 
A 
B 
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7.1.8 Role of ERK1/2, p38 MAPK, and PI3K/Akt    
         signaling in H2O2 PC.  
In accordance with the widely accepted role of protein kinases in 
cardioprotection against many stimuli like oxidative stress, we 
evaluated, by immunoblot analysis, the phosphorylation, i.e. the 
activation, of three fundamental protein kinases: ERK1/2, p38 MAPK, 
and PI3K/Akt. Figure 7-9 A reports representative immunoblots of 
cardiomyocytes preconditioned with 1-100 µM H2O2 for 10 min. 
Phospho-ERK1/2 MAPK expression was significantly increased at 
any H2O2 concentrations, while p38 MAPK and Akt were 
significantly activated only by 50 and 100 µM H2O2. To investigate 
the role of these protein kinases in mediating the cardioprotection 
afforded by PC, we pre-treated cardiomyocytes with specific 
inhibitors of Akt-phosphorylation (20 µM LY), ERK1/2-
phosphorylation (20 µM PD) and p38-phosphorylation (20 µM SB) 
for 1 h, before PC. Cell viability in the absence or presence of the 
different inhibitors is reported in Fig. 7-9 B. The three inhibitors alone 
did not influence cell viability. LY and SB significantly reversed the 
cardioprotective effects of PC, while PD did not modify PC protective 
effect against oxidative stress, suggesting a role of p38 MAPK and 
Akt in the cardioprotection elicited by H2O2-PC. To investigate the 
role of p38 MAPK and Akt in the induction of antioxidant and phase 
II enzymes, cardiomyocytes were pre-treated with LY or SB for 1 h 
before H2O2 PC and GR, TRred, CAT, and NQO1 protein level was 
evaluated by immunoblot analysis (Figure 7-10). LY and SB 
significantly inhibited the induction of  GR, CAT and TRred due to 
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PC. Surprisingly, p38 and Akt inhibitors were not able to reduce the 
induction of NQO1, indicating a role of the two kinases only in the 
induction of GR, CAT and TRred. Enzyme activities, measured in the 
same experimental conditions, are in agreement with the 
immunoblotting data (Table 7-2). DMSO, the vehicle of PD, LY and 
SB, did not influence any parameters (data not shown). 
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Figure 7-9: Role of ERK1/2, Akt, and p38 MAPK in H2O2 cardioprotection.  
A: cardiomyocytes were preconditioned with 1–100 µM H2O2 for 10 min. Cell 
lysates were immunoblotted with antibodies specific for phospho-ERK1/2, 
phospho-p38, and phospho-Akt. Representative immunoblots of 3 different 
experiments are reported. B: cardiomyocytes were incubated with PD-98059 
(PD), LY-294002 (LY), and SB-203580 (SB) before H2O2-PC and after 24h were 
exposed to oxidative stress. Cellular damage was assessed by MTT assay and 
reported as %cell viability compared with control_. Each bar represents the 
means ± SD of 4 independent experiments. Data were analyzed by one-way 
ANOVA followed by Bonferroni’s test. *P < 0.05, with respect to control -;  
°P < 0.05, with respect to stress (control +); ^P < 0.05, with respect to H2O2-PC. 
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Figure 7-10: Role of Akt and p38 MAPK in H2O2-PC induction of phase II 
enzymes. Cardiomyocytes were incubated with LY or SB before H2O2-PC. Cell 
lysates were immunoblotted with antibodies for GR, TRred, CAT, and NQO1. 
Representative immunoblots of 3 different experiments are reported. White line 
inserted in NQO1 blot represents a skipped line. Results of scanning densitometry 
analysis performed on 3 independent autoradiographs are presented. Relative 
amounts (means ± SD) were normalized to the intensity of the same β-actin blot 
and represented as fold increase in respect to controls. Data were analyzed by 
one-way ANOVA followed by Bonferroni’s test. *P < 0.05, with respect to 
control; °P < 0.05, with respect to PC.  
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Table 7-2: Effects of LY and SB on GR, TRred, CAT, and NQO1 activities after 
H2O2-PC 
 GR (mU/mg 
protein) 
TR 
(nmol/min/mg 
protein) 
CAT 
(nmol/min/mg 
protein) 
NQO1 
(mU/mg 
protein) 
Control 10.92±1.18 52.72±1.22 39.12±2.73 10.17±1.54 
PC 14.48±0.36* 76.77±5.94* 63.87±5.54* 20.38±2.85* 
LY 10.421±0.62° 54.54±2.01° 40.10±1.45° 10.00±1.10° 
SB 10.14±0.79° 49.19±6.96° 38.41±3.39° 19.56±0.26° 
LY+PC 10.87±1.32° 64.25±3.59*° 49.62±1.34*° 20.54±2.75* 
SB+PC 11.78±1.04° 65.13±7.53*° 49.95±4.95*° 19.87±1.42* 
 
Value represent means ± SD of 4 independent experiments. Data were analyzed 
by one-way ANOVA followed by Bonferroni’s test. Cardiomyocytes were 
incubated with LY-294002 (LY) or SB-203580 (SB) before H2O2 preconditioning 
(PC), and after 24 h cells were lysed for enzymatic activity measures. *P < 0.05, 
with respect to control; °P < 0.05, with respect to PC. 
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7.2 Effects of SF on carbonyl stress induced by  
     MG in cardiomyocytes 
 
7.2.1 Effects of methylglyoxal on cell viability in 
          cardiomyocytes    
The first point was to evaluate the potential cytotoxicity of 
methylglyoxal (MG) and to determine the IC50 value in  primary 
cultures of neonatal rat cardiomyocytes.  
Cells were treated with increasing MG concentrations (0.1-5 mM) and 
the MTT cell viability assay was assessed after 24 h (fig 7-11).  
At the lowest MG concentrations (0.1-0.5 mM) cell viability was 
comparable to those of control cells, while 0.75-5 mM MG 
siginficantly reduced cell viability compared to control cells. In 
particular, at 1.0 mM cell viability was 50% lower than control cells. 
We decided to choose the concentration of 1.0 mM as an IC50 value in 
subsequent experiments. 
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Figure 7-11: Effect of MG on cell viability of cultured cardiomyocytes. Cells 
were treated with MG (0.1-5 mM) for 24 h. Cell viability was assessed by the 
MTT assay and reported as % cell viability compared with Control. Each bar 
represents means ± SD of 4 independent experiments. Data were analyzed by one-
way ANOVA followed by Dunnett’s ttest: *p< 0.05 vs Control 
 
 
7.2.2 SF protection against MG-induced damage 
Subsequently, we evaluated the possible protective effect of SF 
against carbonyl stress induced by MG. Cardiomyocytes were pre-
treated with 5µM SF for 24 h, exposed to MG 1 mM and after 24 h 
cell viability was determined by MTT assay (figure 7-12). 5 µM SF 
was chosen because it has been previously shown that this is the 
minimum concentration able to evoke the maximum protective effect 
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against oxidative stress in (Angeloni et al. 2009). Treatment with SF 
significantly increased cell viability compared to cells exposed only to  
MG (Fig. 7-12); although cell viability was significantly lower 
compared to that measured in control cells. 
 
 
 
Figure 7-12: Protective effect of SF against carbonyl stress induced by MG. 
Cells were pre-treated with  5µM SF for 24 h before the addition of 1mM MG. 
Cell viability was assessed by the MTT assay and reported as % cell viability in 
comparison to control. Each bar represent means ± SD of  3 independent 
experiments. Data were analyzed by one-way ANOVA followed by Bonferroni’s 
test: *p< 0.05 vs Control cells; °p< 0.05 vs MG 
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To better understand the fate of cells exposed to MG, we evaluated the 
activation and activity of caspase-3. Cells were pre-treated with 5 µM 
SF for 24 h, exposed to 1 mM MG and after 24 h cells were lysed and 
proteins extracted for immunoblotting or caspase 3 activity (Figure 7-
13). Results indicate that MG increase protein content of caspase 3 
active form (17 kDa fragment) and concurrently decrease caspase 3 
pro-inactive form in respect to Control. In agreement with MTT data, 
pre-treatment with SF reduces the formation of the low molecular 
weight fragment in MG exposed cells, indicating that this compound 
is able to counteract apoptotic cell death induced by MG. To confirm 
these results, caspase 3 activity has been evaluated in the same 
experimental conditions (Fig. 7-13 B). Exposure to MG causes a 
significant increase in the activity of the enzyme compared to control 
cells, meanwhile pre-treatment with 5 µM SF significant decrease 
caspase 3 activity in MG treated cells compared to cells exposed to 
MG but not pre-treated with SF. 
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a) 
 
 b) 
          
Figure 7-13: SF protective effects against MG-induced apoptosis in 
cardiomyocytes Cells were pre-treated with  5µM SF for 24 h before the addition 
of 1mM MG. a) Cell lysates were immunoblotted with caspase-3 antibody that 
detects both full length caspase-3 (35kDa) and the large fragment of caspase-3 
resulting from cleavage (17 kDa). b) Caspace-3 activity was measured 
spectrofluorimetrically by hydrolysis of the peptidesubstrate Ac-DEVD-AMC. 
Each bar represent means ± SD of  3 independent experiments. Data were 
analyzed by one-way ANOVA followed by Bonferroni’s test: *p< 0.05 vs Control 
cells; °p< 0.05 vs MG 
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7.2.3  SF effect against MG-induced ROS production in 
cardiomyocytes 
 
GLO1 is a GSH-dependent enzyme and excess MG presents serious 
toxic effects since it depletes GSH via a covalent bond. As GSH is one 
of the most important endogenous antioxidant molecules, its depletion 
could be related to an increase in ROS. To verify if SF is able to 
counteract oxidative stress in MG exposed cardiomyocytes we used 3 
different probes, DCHF-DA, DHE, and MitoSOX to measure 
intracellular ROS production. Representative confocal fluorescent 
micrographs of cardiomyocytes pre-treated with 5 µM SF for 24 h, 
exposed to 1 mM MG and stained with DHE or MitoSox are shown in 
figure 7-14. MG induced a marked increase in DHE and MitoSox 
fluorescence intensity, while SF was able to maintain fluorescence 
intensity to value comparable to control cells. SF alone had no effect 
on fluorescence intensity of cells stained with DHE and MitoSox. 
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Figure 7-14: Confocal microscopy analysis of SF effect on MG-induced ROS 
production. Cardiomyocytes were treated with 5 µM SF for 24 h before the 
addiction of 1mM MG. Cytosolic ROS production was measured using DHE and 
mitochondrial ROS production by MitoSOx staining. Scale bar 10 µm 
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Semi-quantitative measurements by fluorescent plate reader of DCHF-
DA, DHE and MitoSox stained cardiomyocytes are reported in figure 
7-15. MG exposure induced a significant increase in intracellular ROS 
levels. In particular, the highest increase was obtained with DCHF-
DA, the less specific probe able to detect non only H2O2 but also 
several one-electron-oxidazing species (Kalyanaraman et al. 
2011)(Fig.7-15a). In agreement with the results obtained by confocal 
microscopy, MG treatment significantly increased the fluorescence 
intensity of DHE and MitoSox that more specifically target 
superoxide (Fig.7-15b and c). SF was able to counteract the 
intracellular ROS level increase induced by MG, maintaining 
fluorescence intensity of the 3 probes to level comparable to control 
cells. 
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Figure 7-15: Fluorimetric assays of SF effect on MG-induced ROS generation. 
Cardiomyocytes were treated with 5µM SF for 24 h before addition of 1 mM MG. 
A)Intracellular ROS levels were determined with the peroxide-sensitive probe 
DCHF-DA. B)Cytosolic ROS levels were determined with DHE. C)Mitochondrial 
ROS levels were determined with MitoSox. Each bar represent means ± SD of  4 
independent experiments. Data were analyzed by one-way ANOVA followed by 
Bonferroni’s test: *p< 0.05 vs Control cells; °p< 0.05 vs MG 
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To better elucidate SF role in counteracting oxidative stress, total 
antioxidant activity (TAA) was evaluated by ABTS assay (Fig.7-16). 
SF alone was able to significantly increase TAA in respect to control 
cells, while MG significantly reduced this value. Interestingly, SF was 
able to restore TAA levels of MG treated cardiomyocytes to values 
comparable to control cells. 
 
 
 
Figure 7-16: SF effects on cardiomyocytes total antioxidant activity. 
Cardiomyocytes were treated with 5 µM SF for 24 h before addition of 1 mM MG. 
Cell lysates were submitted to the ABTS radical cation decolorization assay and 
the antioxidant activity of the cells were expressed as mean ± SD of µmol of trolox 
antioxidant activity per mg of protein. Data were analyzed by one-way ANOVA 
followed by Bonferroni’s test: *p< 0.05 vs Control cells; °p< 0.05 vs MG 
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7.2.4 Modulation of GLO1 by SF  
Recently it has been shown that the upregulation of GLO1 enzyme is 
modulated by Nrf2, in a manner similar to what happens for the 
antioxidant / detoxifying phase II enzymes. Since SF is able to induce 
the translocation of Nrf2 from the cytosol to the nucleus, thereby 
regulating phase II enzymes, we hypothesized that it might be also 
able to up-regulate GLO1 . To test this hypothesis, we evaluated the 
effect of SF on GLO1 expression and activity. 
Cells were treated with 5 µM SF for different time points (Figure 7-
17). GLO1 protein expression significantly increases compared to that 
measured in control cells after 6 h SF treatment, and this induction 
becomes even more pronounced after 24-48 hours of treatment  
(Figure 7-17a). To relate GLO1 overexpression to its functional 
activity, cardiomyocytes were treated with 5 µM SF and GLO1 
enzymatic activity was measured at different time points (1-48h) 
(Figure 17-7 b). After 1 and 6 h GLO1 activity was slightly increased 
but not significantly different from control cells. After 24 and 48 h SF 
was able to significantly increase GLO1 activity with respect to 
untreated cells.  
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b) 
 
 
 
 
 
 
 
 
 
 
Figure 7-17: Effects of SF on protein expression and enzymatic activity of 
GLO1 in cardiomyocytes exposed to MG. Cells were treated with 5 µM SF for 
different time (1, 6, 24, 48 h). a)protein expression was assessed by 
immunoblotting analyses. Results of scanning densitometry analysis performed on 
3 independent autoradiographs are presented. Relative amounts (means ± SD) 
were normalized to the intensity of the same β-actin blot and represented as fold 
increase in respect to controls. b) enzymatic activity of GLO1 was assessed by 
spectrofotometric assay. Each bar represent means ± SD of  three independent 
experiments. Data was analyzed by one-way ANOVA followed by Dunnet’s test: 
*p< 0.05 vs Control cells 
 
 
 
 
 
 
 
 
CT
RL 1 h 6 h
 
24
 
h
48
 
h
0
200
400
600
*
*
                 SF 5 µM
µµ µµm
o
l/m
in
/m
g 
pr
o
te
in
135 
 
 
 
7.2.5 Effects of SF on AGEs formation in cardiomyocytes   
         exposed to MG 
Finally, we evaluated the effect of SF on the production of AGEs. 
Cells were pre-treated with 5 µM SF for 24 hours and subsequently 
exposed to 1 mM MG for 24 hours and AGE levels were measured 
with an ELISA assay able to identify the main AGEs. In cells not 
treated with SF the exposure to MG caused a significant increase in 
the production of AGEs compared to control cells (Fig.7-18). Pre-
treatment with SF, in contrast, significantly reduced the formation of 
AGEs compared to cells exposed to MG, with values very similar to 
control cells 
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Figure 7-18: Effects of SF on AGEs formation in cardiomyocytes exposed to 
MG.  Cardiomyocytes were treated with 5 µM SF for 24 h before addition of 1 
mM MG, and AGE formation was evaluated by AGE-ELISA using a specific anti-
AGE antibody. Each bar represent means ± SD of  3 independent experiments. 
Data were analyzed by one-way ANOVA followed by Bonferroni’s test: *p< 0.05 
vs Control cells; °p< 0.05 vs MG 
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7.3 Effects of SF on carbonyl stress induced by  
     MG in SH-SY5Y cell line 
 
7.3.1 Effects of methylglyoxal on cell viability in  
         SHSY-5Y cell line 
To evaluate the potential cytotoxicit effect of MG, SH-SY5Y cells 
were treated with increasing concentrations (0.1-5 mM) of MG for 24 
h, after which cell viability was assessed by MTT assay (Figure 7-19). 
At the concentrations 0.25-5 mM, MG induced a significant reduction 
of cell viability compared to control cells. In particular, 0.5 mM MG 
reduced cell viability by 50% compared to the control (IC50). 
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Figure 7-19: Effect of MG on cell viability in SHSY-5Y cell line. Cells were 
treated with MG (0.1-5 mM) for 24 h. Cell viability was assessed by the MTT 
assay and reported as % cell viability compared with controls. Each bar 
represents means ± SD of  4 independent experiments. Data were analyzed by 
one-way ANOVA followed by Dunnett’s test: *p< 0.05 vs Control cells 
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7.3.2 SF protective effects against MG-induced damage in  
         SHSY-5Y cell line 
The next step was to evaluate the possible protective effect of SF 
against glycative damage induced by MG in SH-SY5Y neuroblastoma 
cell line. 
Cells were treated with 5 µM SF for 24 h and then exposed to 0.5 mM 
MG for 24 h. Cell viability was assessed by MTT assay (Figure 7-20). 
As previously reported, MG induced a significant reduction of cell 
viability by about 50% compared to control cells. SF treatment 
significantly increased cell viability compared to cells exposed to MG, 
even if cell viability was significantly lower compared to that 
measured in control cells. To confirm these data, LDH release was 
measured evaluating LDH activity in the culture medium (Figure 7-
21). SH-SY5Y were treated with 5 µM SF for 24 h and then exposed 
to 0.5 mM MG for 24 h. As expected, MG treatment induced a 
significant and strong increase of LDH release, while SF treatment 
was able to maintain LDH activity at level comparable to control cells. 
Moreover, to better understand the fate of cells exposed to MG, we 
evaluated the activity of the pro-apoptotic enzyme caspase-3in the 
same experimental conditions (figure 7-22). MG significantly 
increased caspase-3 activity in SH-SY5Y, indicating that at least part 
of the cells undergo apoptotic cell death, while SF treatment 
significantly reduced caspase-3 activity compared to cells exposed to 
MG. Interestingly, in MG treated cells SF was able to maintain both 
LDH release and caspase 3 activity to value comparable to control 
cells. 
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Figure 7-20: Protective effect of SF against carbonyl stress induced by MG in 
SHSY-5Y cell line. Cells were treated with 5µM SF for 24 h before the addition 
of 0.5 mM MG. Cell viability was assessed by the MTT assay and reported as % 
cell viability in comparison to control. Each bar represent means ± SD of  3 
independent experiments. Data were analyzed by one-way ANOVA followed by 
Bonferroni’s test: *p< 0.05 vs Control cells; °p< 0.05 vs MG 
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Figure 7-21: Effects of SF on LDH activity in cardiomyocytes exposed to MG. 
Cells were treated with 5µM SF for 24 h before the addition of 0.5 mM MG. LDH 
activity was assessed by spectrometric assay and reported as mU/mg of protein 
Each bar represent means ± SD of  3 independent experiments. Data were 
analyzed by one-way ANOVA followed by Bonferroni’s test: *p< 0.05 vs Control 
cells; °p< 0.05 vs MG 
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Figure 7-22: SF protective effects against MG-induced apoptosis in SH-SY5Y 
cell line. Cells were treated with 5µM SF for 24 h before the addition of 0.5 mM 
MG. Caspace-3 activity was measured spectrofluorimetrically by hydrolysis of the 
peptide substrate Ac-DEVD-AMC. Each bar represent means ± SD of 3 
independent experiments. Data were analyzed by one-way ANOVA followed by 
Bonferroni’s test: *p< 0.05 vs Control cells; °p< 0.05 vs MG 
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7.3.3
 
SF effects against MG-induced ROS          
production in SH-SY5Y 
Since it has been demonstrated that MG induces oxidative stress in 
neuronal cells (Angeloni et al. 2013) and that SF exerts its protective 
action through the induction of antioxidant/ detoxifying phase II 
enzymes, we investigated SF ability to counteract MG-induced 
intracellular ROS production by the DCFH-DA assay. Cells were 
treated with µ5 M SF for 24 hours and then exposed to 0.5 mM MG 
for 6 hours (Fig.7-23).  
In cells not treated with SF, MG exposure resulted in a significant 
increase in intracellular ROS production compared to control cells. SF 
treatment, in contrast, significantly reduced the formation of 
intracellular ROS compared to cells exposed to MG. 
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Figure 7-23: Effects of SF on intracellular ROS formation in SHSY-5Y cell line 
exposed to MG.  Cells were treated with 5 µM SF for 24 h before the addition of 
0.5 mM MG. Intracellular ROS levels were determined with the peroxide-sensitive 
probe DCHF-DA. Each bar represent means ± SD of  4 independent experiments. 
Data were analyzed by one-way ANOVA followed by Dunnets’s test: *p< 0.05 vs 
Control cells; °p< 0.05 vs MG  
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7.3.4 Effects of SF on intracellular levels of reduced  GSH       
         in SHSY-5Y exposed to MG   
A reduction in  intracellular levels of reduced GSH occurs in 
conditions of oxidative stress, so we evaluated the effect of SF on 
intracellular reduced GSH levels by the MCB assay. Cells were 
treated with 5 µM SF for 24 h and exposed to 0.5 mM MG (Fig.7-24). 
SF alone was able to increase reduced GSH levels compared to 
control cells. Exposure to MG caused a significant decrease in  GSH 
levels compared to control cells, meanwhile treatment with SF 
significantly increase the amount of reduced GSH compared to control 
cells. 
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Figure 7-24: Effects of SF on intracellular levels of reduced GSH in SHSY-5Y 
cell line exposed to MG. Cells were treated with 5 µM SF for 24 h before addition 
of 0.5  mM MG. Reduced GSH levels were assessed by spectrofotometric assay 
MCB and reported as % respect to controls. Each bar represents means ± SD of 4 
independet experiments. Data were analyzed by one-way ANOVA followed by 
Bonferroni’s test: : *p< 0.05 vs Control cells; °p< 0.05 vs MG  
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7.3.5 Effects of SF on protein expression of GLO1 in  
         SHSY-5Y cell line exposed to MG 
 
The glyoxalase system is the most important pathway for the 
detoxification of MG. It comprises two enzymes: GLO1 and GLO2. 
The first catalyzes the conversion of the hemithioacetal, formed by the 
nonenzymatic reaction of GSH with MG, to S-D-lactoylglutathione. 
GLO2 converts S-D-lactoylglutathione to D-lactate, which recycles 
GSH in the process (Thornalley 1993). Recently it has been 
demonstrated that GLO1 is up-regulated through the Nrf2/ARE 
pathway (Xue et al. 2011). As previously underlined, numerous 
studies have highlighted the role of SF as a potent natural phase II 
inducer in different cell models. As phase II enzymes are modulated 
thorough Nrf2/ARE pathway, we have hypothesized that SF could 
modulate also GLO1. Cells were treated with 5 µM SF for different 
time points (1, 6, 24, 48 h) and and GLO1 activity was measured with 
a spectrophotometric assay (figure 7-25). After 1 and 6 h GLO1 
activity was slightly increased but not significantly different from 
control cells. After 24 and 48 h SF was able to significantly increase 
GLO1 activity with respect to control cells.  
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Figure 7-25: Effects of SF on GLO1 activity in SH-SY5Y cell line exposed to 
MG. . Cells were treated with 5 µM  SF for different periods (1, 6, 24, 48 h). 
Enzymatic activity of GLO1 was assessed by spectrofotometric assay.  Each bar 
represent means ± SD of  three independent experiments. Data was analyzed by 
one-way ANOVA followed by Dunnett’s test: *p< 0.05 vs Control cells 
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7.3.6 Protein kinases modulation by MG 
Since we observed that MG induces apoptotic death in SH-SY5Y 
cells, we hypothesized that MG could modulate some of the signal 
transduction pathways involved in the induction of apoptotic cell 
death  
To test our hypothesis, cells were treated with 0.5 mM MG and after 
time points, the activation (phosphorylation) of p38 MAPK, JNK and 
Akt was evaluated by immunoblotting analisys (figure 7-26).  
p38 MAPK and JNK phosphorylation was significantly increased 
already at 30 min and lasted until 24 h. On the other hand, the 
phosphorylation of  the anti-apoptotic kinase Akt was strongly 
reduced at 2, 6 and 24 h.  
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Figure 7-26: Effects of SF on protein expression and enzymatic activity of 
GLO1 in cardiomyocytes exposed to MG. Cells were treated with 0.5 mM MG for 
different time (0.5, 1, 2, 6, 24 h). Cell lysates were immunoblotted with antibodies 
for p-p38, p-JNK and p-Akt. 
 
 
As MG was able to modulate these signaling pathways, we 
subsequently investigated the possible SF effect on the 
phosphorylation of these kinases. Cells were treated with SF for 24 h 
and then exposed to MG for 30 min, to evaluate p38 and JNK 
activation, to MG for 2 h to study Akt activation (figure 7-27). SF 
treatment had no effect on the phosphorylation of p38 and JNK in the 
absence of MG, whereas in cells exposed to 0.5 mM MG, SF was able 
to slight reduce the activation of both kinases compared to cells not 
treated with SF and exposed to MG.  
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On the other hand SF significantly increased Akt activation both in the 
presence and in absence of MG. 
 
 
 
 
 
Figure 7-27: SF counteracts MG-induced protein kinase negative modulation. 
Cells were pre-treated with 5µM SF and after exposed to 0.5 mM MG for 24 h. 
Cell lysates were immunoblotted with antibodies for p-p38, p-JNK and p-Akt. 
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CHAPTER 8 
 
8. Discussion  
 
In recent years the incidence of chronic degenerative diseases has 
increased. These diseases have a sneaky and inexorably progressive 
course that is brought to light when the harm to the patient is already 
in an advanced stage precluding, in almost all cases, the possibility of 
an effective treatment that is not only symptomatic. Among them, 
ischemic heart disease represents the leading cause of death and 
disability in the Western world, and projections indicate that this 
record will retain at least until 2030. Great attention has been direct to 
the identification of novel therapeutic and preventive strategies to 
counteract the deleterious effects induced by ischemic heart disease. 
Although nowadays available therapies are good, morbidity and 
mortality are still very high. Recently there has been considerable 
improvement in the treatment of acute ischemic heart disease through 
procedures that enable the rapid restoration of blood flow to the 
affected area of the myocardium. Such treatment is also known as 
reperfusion therapy. However, even if blood flow restoration is 
essential for the viability of the heart, it induces a burst of ROS 
generation that exacerbates ischemic injury. From this point of view, a 
promising therapeutic strategies is ischemic preconditioning (PC) that 
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is recognized as one of the most potent protective mechanisms against 
myocardial ischemic injury. Ischemic PC is a phenomenon in which a 
brief exposure to ischemia renders the heart more resistant to a 
subsequent sustained ischemic insult. Many studies (Schulz et al. 
2004) have supported the hypothesis that ROS might play an 
important role both in ischemic/reperfusion injury and ischemic PC. In 
this thesis, we clearly observed this paradoxical effect; in fact, 100 
µM H2O2 were able to counteract or exacerbated oxidative stress 
depending on the exposure time: 10 min led to a protective pattern, 
whereas 30 min caused a marked cell death. Moreover, we measured a 
substantial reduction of intracellular ROS production in H2O2 PC 
treated cardiomyocytes, postulating that H2O2 PC elicits its 
cardioprotective effect through the modulation of the intracellular 
antioxidant defense system. The capacity of cells to maintain cellular 
homeostasis during oxidative stress resides in rapid activation or 
induction of protective enzymes, which in turn decrease oxidative 
stress by reducing ROS. Interestingly, H2O2 PC was able to induce 
fundamental antioxidant and phase II enzymes like NQO1, GR, TR 
and CAT but failed to induce GST, SOD and GPX. This disjointed 
regulation was unexpected, as it has been reported that all these 
enzymes are regulated by the same transcription factor Nrf2 
(Brigelius-Flohe et al. 2006; Purdom-Dickinson et al. 2007; Zhu et al. 
2008). In agreement with these findings, we observed a marked 
translocation of Nrf2 to the nucleus immediately after H2O2 PC 
induction and its up-regulation after 6 h from H2O2 PC. To better 
clarify this point we evaluated the effect of H2O2 PC on another 
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transcription factor belonging the same Nrf2 Cap’n’Collar 
transcription factorfamily: Nrf1. Although Nrf2 has been shown to be 
crucial in the activation of genes regulated by the antioxidant  
responsive element (ARE), the involvement of Nrf1 in ARE function 
has also been demonstrated through transfection studies and gene 
expression analysis in knockout cells and animals (Biswas et al. 
2009). Gene targets of Nrf1 include genes encoding enzymes involved 
in GSH biosynthesis and other oxidative defence enzymes (Biswas et 
al. 2009). Our data demonstrated that H2O2 PC led to a marked 
translocation of Nrf1 to the nucleus. Interestingly,  It was observed 
that Nrf1 has the potential to play an important role in modulating the 
response to oxidative stress by functioning as a trasdominant repressor 
of Nrf2-mediated activation of ARE-dependent gene transcription. So 
we can hypothesize that H2O2 PC is able to induce both Nrf2 and Nrf1 
and their combined translocation to the nucleus leads to this particular 
pattern of phase II enzymes activation. Further studies will be 
necessary to clarify this point. The role of MAPKs in PC signal 
transduction has been addressed by manyAuthors, but only few 
studies have focused on the role of H2O2  in PC signal pathways and 
data are not conclusive (Nakano et al. 2000; Yue et al. 2000; 
Hausenloy et al. 2006). It is commonly acceptedthat phosphorylation 
of ERK 1/2 in cardiac myocytes during early reperfusion serves as a 
defence mechanism against ischemic stress stimuli (Yue et al. 2000). 
The role of ERK 1/2 as a potential mediator of protection in the 
setting of PC has been controversial, with some studies supporting its 
role (de Silva 2004; Gong et al. 2004) and several studies failing to 
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demonstrate a role of ERK 1/2 (Mockridge et al. 2000; Mocanu et al. 
2002; Button et al. 2005). We observed that ERK 1/2 is markedly 
activated immediately after H2O2 PC and this activation occurred also 
with not cytoprotective H2O2 concentrations. Inhibition of ERK 1/2 by 
PD did not influence H2O2 PC cardioprotection against a subsequent 
oxidative stress, indicating that ERK 1/2 is probably not involved in 
this mechanism. Our data are in agreement with the result of  
Mockridge et al. (2000) that observed a rapid, transient 
phosphorylation of ERK 1/2 after PC, but ERK 1/2 blocked by PD did 
not effect cytoprotection elicited by PC. Mocanu et al. (2002) 
demonstrated that ERK 1/2 cascade is not implicated in ischemic PC 
isolated perfused rat hearts. The role of p38 MAPK in the protection 
provided by PC remains controversial. Many studies confirmed role of 
p38 MAPK as a potential mediator of PC-induced cardioprotection, 
while others have shown that pharmacologically inhibition of p38 
MAPK during ischemia-reperfusion confers cardioprotection in non-
preconditioned hearts (these discrepancies are reviewed in Hausenloy 
and Yellon, 2006). Bell et al. (2008) observed that these different 
views about the role of p38 MAPK in mediating PC could be ascribed 
to an inappropriate use of its pharmacological inhibitor SB. In 
particular, they attributed to DMSO, the common SB vehicle, 
antioxidant properties that can protect also non-preconditioned hearts. 
In our study H2O2 PC was found to induce a significant increase of 
p38 MAPK  phosphorylation and, in the presence of SB, the beneficial 
effect of H2O2 PC was ablated. To ascertain the influence of DMSO, 
this compound was added also in control and stressed cells evidencing 
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no effects. Activation of the PI3K/AKT pathway has been 
demonstrated to play a key role in both early and delayed myocardial 
PC, contributing to the recruitment of multiple endogenous 
cardioprotective pathways to reduce myocardial damage after 
ischemia and reperfusion (Hausenloy et al. 2005; Hausenloy et al. 
2006). In this present studywe demonstrated that H2O2 PC induced a 
significant Akt phosphorylation, and, more important, the 
cardioprotective effect of H2O2 PC was significantly attenuated by the 
inhibition of PI3K/Akt. Tong et al. (2000) demonstrated that ischemic 
PC protects the heart by activating the PI3/Akt cascade during the PC 
protocol, a finding confirmed by subsequent studies. For example, 
Uchiyama et al. (2004) observed that in adult cardiomyocytes the 
antiapoptotic effect of PC against hypoxia/reoxygenation requires Akt 
signaling leading to phosphorrylation of BAD, inhibition of 
cytocrome c release, and prevention of caspase activation. Moreover, 
Mocanu et al. (2002)demonstrated that wortmannin and LY (PI3 
kinase inhibitors) partially blocked PC cardioprotection in isolated 
perfused rat hearts. Many Authors have demonstrated the involvement 
of p38 MAPK and Akt in Nrf2 activation (Zipper et al. 2000; Owuor 
et al. 2002; Kim et al. 2009), but no studies have been undertaken to 
demonstrate their role in the induction of phase II enzymes in 
cardiomyocytes. Here we report that inhibition of both p38 MAPK 
and Akt in H2O2 PC significantly reduced protein expression and 
activity of GR, Tred and CAT while did not modify NQO1, in 
agreement with data obtained by Manandhar et al. (2007) on murine 
keratinocytes in which the pharmacological inhibitors of p38 MAPK, 
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PI3K/Akt, and PKC did not alter 3H-1,2-dithiole-3-thione induction of 
NQO1.  
As it has been widely emphatized in this thesis, more and more studies 
evidencing a role of carbonyl stress, as well as oxidative stress, in the 
development of chronic degenerative diseases. The main reactive 
carbonyl species present in physiological systems, responsible for 
glycation, is methylglyoxal (MG). The enzymatic defenses against 
MG-induced glycation consist of 2 enzymes, GLO1 and GLO2 , that 
forms the glyoxalase system. Recently, it has been observed that 
GLO1 expression is regulated by Nrf2/ARE pathway. Between the 
substances able to modulate this pathway, great attention has been 
dedicated to the natural compound SF, derived from glocoraphanine. 
Based on this observations further aim of this thesis was to study the 
effect of SF in counteracting glycative MG-induced damage in 
cardiomyocytes, moreover, for this time, we demonstrated that SF 
counteracted MG-induced apoptotic cell death, reduced ROS 
generation and AGE production, and induced GLO1 expression and 
functional activity. Likely, SF elicits a multi-target behavior against 
MG-induced damage: it up-regulates GLO1 enhancing the cell ability 
to detoxify MG, and acts as an indirect antioxidant reducing ROS 
produced by MG. Even if the exact role of the glyoxalase system in 
cardiovascular disease has not been fully elucidated, it has been 
observed that in hemodialysis patients, the GLO1 A491C 
polymorphism is associated with a significantly higher prevalence of 
cardiovascular disease and peripheral vascular disease risk (Kalousova 
et al. 2008). Moreover, Wang et al. (2010) demonstrated that 
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thioredoxin inactivation and significantly protected cardiomyocytes 
from I/R injury. These results suggest that any intervention able to 
reduce intracellular MG concentration, like GLO1 induction by SF 
treatment, could attenuate injury endured in myocardial I/R processes. 
More and more scientific evidences are confirming a role of glycation 
also in the onset of diseases such as Alzheimer’s disease (Luth et al. 
2005). AGEs are able to cross-link proteins in Aβ deposits and 
neurofilamentes AD level leanding to tau hyperphosphorylation. It has 
also been observed that MG is a neurotoxic mediators of oxidative 
stress in the progression of AD inducing apoptosis and cellular 
dysfunction. For these reasons it can be reasonably hypothesized that 
AD might be strongly linked to an increase in MG levels due to an 
oxoaldehyde detoxification impairment or an altered endogenous 
oxoaldehyde production. Since we have demonstrated that SF is able 
to counteract MG-induced damage in cardiomyocytes, last aim ofthis 
thesis was to study the ability of SF to counteract glycation in SHSY-
5Y neuroblastoma cell line. The human SHSY-5Y neuroblastoma cell 
line is well characterized and has been widely used as a model system 
to investigate the pathological effects of various neurotoxic 
compounds. In addition, SHSY-5Y cell costitutively express a 
receptor for AGEs. They also are highly sensitive to MG challenge 
due to a defect in thei antioxidant and detoxifying abilities that 
prevent efficient scavenging and that elicits extensive caspase -9-
dependent apoptosis (Li et al. 2011). As already observed, MG 
accumulation is responsible for detrimental effects on neurons 
viability (Di Loreto et al. 2004; Di Loreto et al. 2008). Our data 
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demonstrated that SHSY-5Y death occurs through the induction of 
ROS-mediated cell death. Indeed, MG was as able to increase 
intracellular ROS level and to decrease reduced GSH. SF treatment 
was able to counteract Mg triggered cell death and to reduce ROS 
production. MAPK signaling pathways are activated by many 
extracellular stimuli such as cytokines, growth factors and oxidative 
stress (Seger et al. 1995). It has been indicated that MAPK-signaling 
cascades are involved in the process of apoptosis (Cross et al. 2000). 
In our study, MG was able to phosphorylate the pro-apoptotic kinases 
p38 MAPK and JNK at already 30 min from MG exposure and to 
reduce the phosphorylation of the anti-apoptotic kinase Akt at longer 
exposure time. Our data are in agreement with the results of Huang et 
al. (2008)that observed an increased phosphorylation of JNK and p38 
MAPK after 400 µM MG treatment in neuro-2A cells. Interestingly, 
our data demonstrate that SF treatment is able to revert this pro-
apoptotic MAPK modulation, confirming its ability to counteract MG 
induced apoptosis. Since we have previously demonstrated that SF is 
able to significantly increase GLO1 protein level and activity in 
cardiomyocytes, we tested its effect on GLO1 regulation also n 
SHSY-5Y neuroblastoma cell line. In agreement with the dataobtained 
in cardiomyocytes, Sf increases GLO1activity demonstrating its 
pleiotropic effect in counteracting MG-induced damage: SF is able to 
counteract MG-induced apoptosis both modulating fundamental 
kinases involved in pro-apoptotic signaling cascades and enhancing 
MG detoxifying system.  
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In conclusion this thesis show that it is possible to counteract the 
oxidative and carbonyl stress using different  strategies. To one side 
our data demonstrate that the protection enduced by H2O2 is mediated 
by detoxifying and antioxidant phase II enzymes induction, regulated, 
not only by transcriptional factor Nrf2, but also by Nrf1. These novel 
data contribute to our understanding of the mechanisms of H2O2 in 
triggering ischemic PC, opening new researches on the molecular 
mechanisms at the base of the cardioprotection induced by 
preconditioning. On the other side our data represent an innovative 
result because for the first time it was demonstrated the possibility of 
inducing GLO1 by SF supplementation. This strategy represent an 
efficient approach for the protection from oxidative and carbonyl 
stress. These result pave the way to new and more important studies 
because glycation in involved not only in cardiovascular diseases or in 
Alzheimer pathology but also in other important chronic degenerative 
diseases, in ageing, in diabetes, therefore the SF supplementation 
could represent an efficiency protective/preventive strategy. 
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